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Chapter 1: Introduction 
1.1 Membrane trafficking in yeast  Eukaryotic cells contain organelles, each having a different protein and lipid composition essential for their function. Membrane trafficking describes the movement of proteins and lipids between different cellular compartments to maintain organelle homeostasis. Specificity in membrane trafficking is critical for cell viability to ensure that proteins and lipids are distributed to the correct organelle, allowing each organelle to perform a specialized function. Errors in membrane trafficking have been linked to a large spectrum of diseases, underlying the importance of understanding this process (Aridor and Hannan, 2000, 2002). Many of the genes required for membrane trafficking were identified by mutational studies of the yeast Saccharomyces cerevisiae in the lab of Randy Schekman (Novick et al., 1980). There is a high degree of conservation between yeast and human membrane trafficking pathways making yeast a very powerful tool for studying this process. A number of genetic tools are available for studying yeast and the reduced complexity of unicellular yeast permits the elucidation of membrane trafficking mechanisms in higher, multicellular eukaryotic organisms. Proteins are transported along pre-determined pathways that are categorized by the organelles they contain. The two principle membrane trafficking pathways in eukaryotes are the secretory and endocytic pathways.  
1.1.1 The secretory pathway 
 In cells, approximately one third of proteins travel through the secretory pathway which begins at the endoplasmic reticulum (ER) and ends at the plasma membrane (PM) (Figure 1.1) (Barlowe and Miller, 2013). Proteins synthesized at the ER and destined for the secretory pathway are packaged into membrane bound compartments called vesicles, and transported to the Golgi apparatus (Golgi) (Bonifacino and Glick, 2004). In mammals individual Golgi cisternae are stacked into a structure with a cis and trans face, and cargo coming from the ER enters at the cis face and exits the Golgi at the trans face. In 




the early Golgi first and exits from the late Golgi (Klumperman, 2011; Suda and Nakano, 2012). The anterograde movement of cargo through the Golgi (cis-to-trans direction) may occur at least in part by a process called cisternal maturation, where early cisternae undergo a gradual transformation into late cisternae (Losev et al., 2006; Matsuura-Tokita 





Figure 1.1 Proteins are transported throughout the cell via multiple membrane 
trafficking pathways. Arrows indicate the direction of movement of vesicles (COPI, COPII and clathrin) between cellular compartments (red indicates anterograde movement, blue indicates retrograde movement and dashed lines indicate autophagy pathways). Membranes of the secretory pathway are outlined in green and endocytic membranes are outlined in blue. (abbreviations: early endosome (EE), late endosome (LE), multivesicular body (MVB), plasma membrane (PM))  
1.1.2 The endocytic pathway 




Wendland, 2001). Endosomes act like sorting stations for cargo and endocytosed material can be sent to various destinations. Cargo can be recycled back to the PM, either directly or through intermediates such as the late Golgi, or travel to the vacuole for degradation via late endosomes/multivesicular bodies (MVBs) (Lemmon and Traub, 2000).  The endocytic pathway balances protein input from the secretory pathway through protein internalization, degradation and recycling.  









Figure 1.2 Selective and non-selective autophagy pathways transport cargo is to the 
vacuole for degradation.  Non-selective and selective (Cvt pathway) macroautophagy pathways are represented schematically. In the selective autophagy pathway oligomers of prApe1 (precursor aminopeptidase 1)/Ams (α-mannosidase) are packaged into Cvt vesicles and transported to the vacuole to be processed. In the non-selective autophagy pathway autophagosomes containing bulk cytosolic components (including Ape1/Ams1) are delivered to the vacuole for processing and degradation. Atg17p is a scaffold protein that is localized to the PAS and is required for non-selective autophagy pathways. Atg9p is a transmembrane protein that is required for PAS formation and is transported to the PAS on membranes from the secretory pathway.  




Balch et al., 1994). Vesicle transport is divided into a series of steps, each regulated by a different class of proteins: vesicle budding, mediated by coat proteins; vesicle tethering/docking, mediated by tethering factors and Rabs; and vesicle fusion, mediated by soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) (Bonifacino and Glick, 2004). These protein classes each add a layer of specificity to membrane trafficking pathways to ensure the fidelity that is essential for cell viability.  
 




paralogue Gea2p act as the GEFs for Arf1p to initiate COPI vesicle formation (Peyroche et 
al., 1996). COPI components are recruited to the membrane as a heptameric complex (also called coatomer) that polymerize and drive vesicle formation (Hara-Kuge et al., 1994). Coatomer structure is well conserved between yeast and mammals with the inner layer consisting of β (Sec26p)- , δ (Ret2p)-, γ(Sec21p)-, and ζ(Ret3p)- COP and the outer layer consisting of α (Cop1p/Sec33p/Ret1p)-, β'(Sec27p)-, ε (Sec28p)- COP (yeast homologues are indicated in brackets) (Barlowe and Miller, 2013).   The inner layer of clathrin-coated vesicles is formed by adaptors that are either multimeric or monomeric and are specific to the site of vesicle budding (McMahon and Mills, 2004). Reminiscent of COPI, active Arf1p is also needed to recruit several of these adaptors complexes to the membrane to initiate vesicle formation (Stamnes and Rothman, 1993; Boehm et al., 2001). Clathrin triskelions, containing three copies of the clathrin light chain and clathrin heavy chain proteins, are brought to specific locations by these adaptors and assemble into an interconnected protein cage to form the vesicle outer layer (Brodsky 
et al., 2001; Fotin et al., 2004).  While COPI, COPII and clathrin coated vesicles assemble differently, subunits that form the inner layer of coatomer (β, δ, γ and ζ) are homologous to subunits of forming the adaptor complexes of clathrin coated vesicles (Schledzewski et al., 1999). Furthermore, while no sequence homology has been found among proteins forming the vesicle outer layers, structural studies show that proteins forming the vesicle outer layers share a similar organization of protein domains (Faini et al., 2013).  




in short distance tethering (Gillingham and Munro, 2003; Yu and Hughson, 2010). Nine MTCs have been identified in yeast and are differentially located throughout the endomembrane system, where they mediate tethering at specific target membranes (Sztul and Lupashin, 2006). MTCs can be grouped together based on the structure of subunit components and the pathways in which they act. The CATCHR (Complex Associated with Tethering Containing Helical Rods) family of MTCs have structurally homologous subunits. This family is composed of the complexes COG (conserved oligomeric Golgi), GARP (Golgi- associated retrograde protein), Dsl1 and the exocyst, which all function in the secretory pathway (Whyte and Munro, 2001, 2002; Yu and Hughson, 2010). CORVET (class C core vacuole/endosome tethering) and HOPS (homotypic fusion and vacuole protein sorting) act in the endocytic pathway and have 4 subunits in common (Peplowska et al., 2007; Solinger and Spang, 2013).  The final class of MTCs in yeast is the TRAPP family (transport protein particle), consisting of TRAPPI, TRAPPII and TRAPPIII which share 6 unique core subunits and function in ER-Golgi trafficking, post-Golgi trafficking and autophagy, respectively (Sacher et al., 2001; Barrowman et al., 2010; Lynch-Day et al., 2010) (to be discussed in more detail below, see section 1.3). MTCs act as master coordinators by interacting with many proteins such as guanine nucleotide exchange factors (GEFs), GTPase accelerating proteins (GAPs), Rabs, Rab effectors, soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), coiled coil tethers and coat proteins, to ensure that vesicles interact with the appropriate target membrane (Cai et al., 2007a; Jackson et al., 2012).   




and Wasmeier, 2004). GEFs activate Rabs by inducing conformational changes in the nucleotide-binding pocket to favor GDP release and allow GTP, which is present in excess over GDP in the cytosol, to bind (Bourne et al., 1990; Bos et al., 2007). GEFs are Rab-specific and promote the association of Rabs to membranes (Pfeffer, 2001). Effector proteins preferentially associate with active Rabs and are recruited to cellular membranes to initiate downstream events required for the docking and fusion of transport vesicles (Grosshans et 






Figure 1.3 The rab cycle. Small Rab GTPases cycle between an active and inactive state through the action of GEFs (guanine nucleotide exchange factors) and GAPs (GTPase accelerating proteins), respectively. Active rabs initiate a pathway by recruiting effectors such as tethering factors that are required for downstream events. Chaperones called GDIs (GTPase dissociation inhibitors) extract inactive rabs from membranes. 
 




SNARES contributes to specificity in membrane trafficking (Sollner et al., 1993; Rothman and Warren, 1994).  
1.3 TRAPP: a conserved multisubunit tethering complex 
1.3.1 The discovery of three TRAPP complexes in yeast The first transport protein particle (TRAPP) subunit identified in yeast was Bet3p (Blocked Early in Transport 3), a 22kDa protein shown to be essential for ER-Golgi transport (Rossi et al., 1995). When Bet3p was immuno-isolated from a yeast lysate it was found in complex with nine additional subunits: Bet5p, Trs20p, Trs23p, Trs31p, Trs33p, Trs65p, Trs85p, Trs120p, and Trs130p (Table 1.1) (Sacher et al., 1998). Subunits were named by their molecular weights with the exception of Bet5p whose gene had been previously identified as a high copy suppressor of a temperature sensitive bet3 allele (Jiang 




















Table 1.1 Yeast and mammalian TRAPP subunits. Mammalian subunits and the corresponding yeast homologues are listed and their presence in TRAPPI (I), TRAPPII (II) and/or TRAPPIII (III) is indicated. TRAPP core subunits are shaded in light blue.  Several years later, the separation of TRAPP complexes by size exclusion was revisited using a Superose 6 column, which has a much higher size exclusion limit. On this column the higher molecular weight peak was resolved into two separate peaks, one appearing at approximately 1000 kDa, containing TRAPPII specific subunits, and an additional peak at the void volume of the column (40MDa), containing Trs85p as well as the core subunits (Choi et al., 2011). This new peak represented a third TRAPP complex and was designated TRAPPIII. TRAPPI subunits but not TRAPPII-specific subunits (Trs65p, Trs120p and Trs130p) co-purified with Trs85p from yeast lysates, and vice versa, supporting the notion that TRAPPIII was a bona fide complex, that had not been resolved from TRAPPII in earlier experiments (Lynch-Day et al., 2010; Choi et al., 2011).   
Mammalian 
subunits 




Following the initial characterization of TRAPPII, the additional TRAPPII subunit, Tca17p, was discovered. Tca17p is a non-essential protein that was identified through its significant homology with the core subunit Trs20p (Montpetit and Conibear, 2009; Scrivens et al., 2009).  In addition to their separation by size, TRAPPI, II and III also display distinct subcellular localizations and are implicated in different cellular processes (Figure 1.5). TRAPPII is localized to the late Golgi where it functions in both the endocytic and secretory pathway; TRAPPIII is essential for constitutive autophagy pathways and accordingly, resides at the PAS; TRAPPI localizes to the early Golgi and is essential for ER-Golgi trafficking (Barrowman et al., 2010).   
1.3.2 Structure and composition of the three yeast TRAPP complexes 




based on their structural similarities; the Bet3 family includes Bet3p, Trs33p and Trs31p and the Sedlin family includes Trs20p, Trs23p and Bet5p (Kim et al., 2006; Cai et al., 2008).   
 
Figure 1.4 The structure and composition of yeast and mammalian TRAPP 





1.3.2.2 TRAPPII EM structure  The structure of native TRAPPII purified from yeast lysates was determined by EM, and revealed the complex to be a dimer (Yip et al., 2010). Each TRAPPII monomer consists of a TRAPPI core, capped on either end by Trs120p or Trs130p and a copy of Trs65p, all together forming a triangular shape, so that two triangular monomers form a diamond (Figure 1.4B). In the TRAPPII structure, both copies of Trs65p appear to link two monomers together and the importance of Trs65p in stabilizing these dimers is evidenced by the absence of dimer formation when TRAPPII was purified from a trs65∆ strain (Yip et 
al., 2010). Consistent with this result, on a size exclusion column, TRAPPII from wild type lysates fractionates at ~ 1MDa whereas TRAPPII from trs65∆ lysates, appears at ~700kDa (Choi et al., 2011). The dimer has two-fold symmetry so that the same surface is exposed on either end of the complex.  Although Tca17p co-fractionates with and interacts genetically with TRAPPII, it co-purifies with the complex in substoichiometric amounts leading to speculation that Tca17p may only transiently associate with TRAPPII (Yip et al., 2010). However size exclusion experiments show that in the absence of Tca17p the interaction between the core and TRAPPII specific subunits is de-stabilized (Choi et al., 2011). Furthermore, Tca17p co-localizes with the TRAPPII subunit, Trs130p, by fluorescence microscopy (Montpetit and Conibear, 2009). The exact location of Tca17p within TRAPPII is not known, but binding experiments between its mammalian homologue, TRAPPC2L, and the mammalian TRAPP core indicate that it may be positioned on the opposite side of the complex from Trs20p/TRAPPC2 (Scrivens et al., 2009).  
1.3.2.3 TRAPPIII EM structure 




additional subunits aside from the core (~200kDa) and a single copy of Trs85p (~85kDa) (Choi et al., 2011).  
  The EM structures of native and recombinant TRAPPIII were recently determined, and shown to be similar. The complex appears “banana-shaped” with Trs85p occupying the top ¼ of the structure and connecting with the core, which occupies the bottom 3/4 of the structure, at the Trs20p end (Figure 1.4B) (Tan et al., 2013). No significant structural changes are observed in the core when it is part of TRAPPIII, in comparison to TRAPPI (which consists of just the core), suggesting that many TRAPPI binding surfaces would remain exposed (Tan et al., 2013).   
1.3.3 TRAPP as a GEF 




well as with recombinant complexes produced in E. coli (Jones et al., 2000; Wang et al., 2000; Kim et al., 2006; Lynch-Day et al., 2010; Tan et al., 2013).  TRAPPII GEF activity has only been demonstrated for the complex purified from yeast lysates, as TRAPPII has not yet been successfully produced in vitro (Lynch-Day et al., 2010). The additional subunits in TRAPPII/III do not alter or mask the Ypt1p binding site but instead they have been proposed to direct the GEF activity of the TRAPPI core to a specific destination within the cell.  
1.3.3.2 TRAPPII may be a GEF for Ypt32 
 TRAPPII subunits interact genetically with the Rabs encoded by YPT31 and YPT32 that act in the late secretory pathway and mutations in TRAPPII-specific subunits perturb Ypt31p localization indicating that TRAPPII and Ypt31/32p function in common pathways (Morozova et al., 2006; Liang and Morozova, 2007; Montpetit and Conibear, 2009; Tokarev 
et al., 2009; Choi et al., 2011). Consistent with this, the TRAPPII complex has been reported to be a GEF for Ypt31/32p. In several studies TRAPPII displayed GEF activity towards Ypt31/32p and not Ypt1p, leading to an elegant model that the addition of TRAPPII-specific subunits convert TRAPPI, a complex acting in the early secretory pathway, into a Ypt32p GEF, that acts further downstream (Jones et al., 2000; Morozova et al., 2006). However, this result has not been repeated by other groups and pull down experiments as well as EM structure analysis demonstrated that TRAPPII purified from yeast lysates binds Ypt1p but not Ypt31/32p (Yip et al., 2010). A possible explanation for the discrepancy between researchers could be different experimental designs. Recombinant TRAPPII has not yet been produced and when the complex is purified from lysates, other proteins may be co-precipitating with the complex, such as the true Ypt31/32p GEF. Alternatively, the integrity of TRAPPII may be altered in certain conditions compromising its Ypt31/32p GEF activity.   
1.3.4 TRAPPI, II, and III act in different membrane trafficking pathways 
1.3.4.1 TRAPPI is essential for ER-Golgi trafficking 









Figure 1.5 TRAPPI, II and III act in multiple membrane trafficking pathways. TRAPPI, TRAPPII and TRAPPIII are indicated by I, II and III, respectively. Arrows indicate the direction of movement of vesicles (COPI, COPII and clathrin) between cellular compartments (red indicates anterograde movement, blue indicates retrograde movement and dashed lines indicate autophagy pathways). Membranes of the secretory pathway are outlined in green and endocytic membranes are outlined in blue. (abbreviations: early endosome (EE), late endosome (LE), multivesicular body (MVB), plasma membrane (PM))  




Golgi trafficking (Figure 1.5). Mutations in TRAPPII-specific subunits disrupt the recycling of the plasma membrane SNARE Snc1p which, when endocytosed, is recycled back to the plasma membrane (PM) via the late Golgi. GFP-Snc1p is normally concentrated at the PM but in TRAPPII mutants it accumulates in the cell interior, indicating that its transport back to the plasma membrane is blocked (Cai et al., 2005; Montpetit and Conibear, 2009). Specific mutations in ypt1 also impair Snc1p recycling through the early Golgi, raising the possibility that just as Ypt1p must be activated by TRAPPI in ER-Golgi trafficking, Ypt1p must be activated by TRAPPII to mediate the entry and exit of cargo at the late Golgi (Lafourcade et al., 2004; Sclafani et al., 2010).  TRAPPII mutants also affect the secretory system at the level of the late Golgi. In these mutants, cargo such as CPY and invertase travelling through the secretory system, accumulate in their Golgi modified form, indicating that exit from the Golgi is blocked (Sacher et al., 2001; Cai et al., 2005). Furthermore, EM analysis of a trs130 mutant revealed the accumulation of toroid-shaped Golgi membranes, a phenotype seen when proteins acting at the level of the Golgi are mutated (Sacher et al., 2001).  Similar to the interaction of TRAPPI with COPII, TRAPPII interacts with the COPI vesicle coat. COPI subunits co-purify with TRAPPII from yeast lysates and TRAPPII mutants cause COPI subunits to improperly localize. Taken together, these results have led to the suggestion that TRAPPII acts to tether COPI vesicles at the Golgi (Cai et al., 2005; Chen et 




TRAPPII-controlled trafficking from the late Golgi is also involved in autophagy pathways. Mutations in TRAPPII-specific subunits cause defects in non-selective and selective autophagy and this defect is linked to the trafficking of Atg9p from the late Golgi to the PAS (Figure 1.5) (Zou et al., 2013). Whereas TRAPPIII has a direct role in PAS assembly (as will be discussed in the next section), TRAPPII appears to affect autophagy pathways indirectly by mediating the anterograde transport of autophagy proteins to the PAS.  
1.3.4.3 TRAPPIII regulates endocytosis and autophagy Several studies have focused on the TRAPPIII complex as it was recently characterized as a completely separate complex from TRAPPI and II. The only TRAPPIII specific subunit, Trs85p, is non-essential, and most of the work aimed at determining the function of TRAPPIII has focused on this subunit. Like TRAPPII mutants, the trs85∆ mutant is defective in Snc1p recycling and accumulates GFP-Snc1p internally, suggesting that TRAPPIII also functions in an endocytic recycling pathway that travels through the late Golgi (Figure 1.5) (Montpetit and Conibear, 2009). Whereas GFP-Snc1p in TRAPPII mutants show various punctate and diffuse patterns of localization, GFP-Snc1p in trs85∆ has a very dramatic phenotype, as it aggregates into very few intense, large punctae in the cell interior, and a negligible percentage of cells show PM localization (Cai et al., 2005; Montpetit and Conibear, 2009; Brunet et al., 2013). Although TRAPPIII and TRAPPII are both involved in Sncp1 recycling, they likely act at different points in the pathway. Chs3p is another cargo that follows a similar route as Snc1p, and defects in its trafficking affect the resistance of cells to the drug Calcofluor white (CFW). Mutations that block its trafficking to the plasma membrane make cells resistant to CFW while mutations that block its retrieval from the PM make cells sensitive to CFW (Valdivia et al., 2002). Interestingly, a 




The most extensively studied function of TRAPPIII is in autophagy as it is essential for the yeast Cvt pathway and contributes to, but is not required for, starvation induced macroautophagy (Meiling-Wesse et al., 2005; Nazarko et al., 2005). Trs85p and Ypt1p co-localize and interact with each other at the PAS and Atg9p-containing membranes, and this interaction is essential for PAS formation (Figure 1.6) (Lynch-Day et al., 2010; Lipatova et 




interfering RNA), cause an increase or decrease in autophagosome formation (Behrends et 
al., 2010) . The Cvt pathway is not conserved in higher eukaryotes such as mammals, but mammalian TRAPPIII may function in autophagy in a similar manner as it does in yeast macroautophagy. 
 
Figure 1.6 TRAPPIII localizes to the PAS and regulates selective and non-selective 




1.3.5 Mammalian TRAPP complexes  TRAPP was initially described in yeast (yTRAPP) but TRAPP has also been characterized in mammalian cells (mTRAPP) and every yeast subunit has a mammalian homologue (Table 1.1). When HeLa cell lysates are separated on a size exclusion column they yield two high molecular weight peaks which represent mammalian TRAPPII and TRAPPIII (Figure 1.4C), but no peak is observed for the equivalent of a TRAPPI core complex (Scrivens et al., 2011; Bassik et al., 2013). This difference may be caused by structural differences between the yeast Trs23p core subunit and its mammalian homologue TrappC4 as discussed in Chapter 3.  Two additional mammalian TRAPP subunitsthat have no identifiable yeast homologues were characterized, and they were both found in the mTRAPPIII complex (Figure 1.4C). The nomenclature adopted for mammalian TRAPP subunits is TrappC# where “#” is  1-13; novel subunits were named TrappC11 and TrappC12 accordingly (Table 1.1) (Gavin et al., 2002; Choi et al., 2011; Scrivens et al., 2011; Bassik et al., 2013). Mammalian TRAPPIs also different from yeast in that several mammalian subunits have more than one isoform. The mammalian homologue of Trs33p, TrappC6, has two isoforms, TrappC6a and TrappC6b, and two Bet3p homologues exist, TrappC3 and TrappC3L (Kümmel et al., 2008; Scrivens et al., 2011).    Consistent with the subunits being largely conserved between yeast and mammals, the function of TRAPPIs also, at least partially, conserved.  Purified mTRAPPII from HeLa lysates exhibits GEF activity for the Ypt1p homologue Rab1 and depleting several TRAPP subunits causes a Golgi fragmentation phenotype, indicating that the complex is required for membrane trafficking which is important for Golgi homeostasis (Yu et al., 2006; Scrivens et al., 2009, 2011; Yamasaki et al., 2009). TrappC3, like its yeast homologue Bet3p, interacts with Sec23 and mTRAPPIII co-precipitates with COPII coat proteins while mTRAPPII associates with COPI coat proteins (Yu et al., 2006; Yamasaki et al., 2009; Bassik 




In yeast, COPII vesicles that have emerged from the ER fuse directly with the Golgi in a process called heterotypic fusion. In mammalian cells, COPII vesicles undergo homotypic fusion to coalesce into the ER-Golgi Intermediate Compartment (ERGIC) (Xu and Hay, 2004). TrappC3 has been localized to the transitional ER and is required for formation of the ERGIC by mediating homotypic COPII fusion, but whether it performs this function within the context of mTRAPPIII is not known (Yu et al., 2006). Additionally, in an in vitro transport assay, the immunodepletion of TrappC3 prevents VSV-G from reaching the Golgi, consistent with this subunit acting in the early secretory pathway (Loh et al., 2005). Similarly, and analogous to the requirement for yTRAPPI in ER-Golgi trafficking, depletion of the mTRAPPIII subunits TrappC11 and TrappC12 arrest the reporter protein ts045VSV-G-GFP at ERES or at peripheral ERGIC apposed to ERES (Scrivens et al., 2011). Mutations in both mTRAPPII and mTRAPPIII specific subunits have been linked to several different human diseases (Brunet and Sacher, 2014).   




The mechanism for the involvement of TrappC2 in collagen secretion was elucidated by TrappC2-depletion experiments in fibroblasts and chondrocytes. Depletion of TrappC2 by siRNA blocked the secretion of pro-collagen II (PCII), which accumulated in the ER, but not smaller cargo such as VSV-G-GFP (Venditti et al., 2012). TrappC3 depletion caused a similar phenotype suggesting that TrappC2 is acting as part of a complex. Venditti et al. further showed that TrappC2 is recruited to ERES through an interaction with the pro-collagen receptor TANGO1, where TrappC2 interacts with the activated form of the COPII GTPase Sar1-GTP. Activated Sar1 facilitates constriction of the growing COPII vesicle, but TrappC2 promotes Sar1 inactivation and membrane dissociation, permitting the vesicle to reach an adequate size to package a 300nm PCII fibril (Venditti et al., 2012). Interestingly, the PCII-specific defect is dependent on the degree of TrappC2 depletion. In the same cells, a more severe knockdown of TrappC2 caused a more general secretion defect, and the same Golgi fragmentation phenotype previously reported was observed (Scrivens et al., 2009; Venditti et al., 2012).   
1.4 The purpose of this thesis 
 For my thesis work I have used yeast as a model system to understand how specific subunits contribute to the integrity of the TRAPP complexes and how these complexes regulate membrane trafficking pathways. Specifically, I addressed the following questions: (1) How do Trs20p and Trs23p, two essential core subunits, contribute to the integrity and function of the yeast TRAPP complexes and what are the implications of these findings for the equivalent mammalian complexes? (2) What are the functional consequences of an interaction between the yeast TRAPPII complex and the Yptp6 GAP Gyp6p and within what cellular context does this interaction occur?  




mediated trafficking pathways and TRAPPIII assembly. These results are presented in Chapter 2 and were published in 2013 in Traffic (Brunet et al., 2013) 
  Trs23p is an essential TRAPP core subunit that links the two ends of yeast TRAPPI together (Figure 1.4A) and is required for Ypt1p directed GEF activity. In Chapter 3 of this dissertation I examined how mutations in Trs23p affect the structural integrity and the function of TRAPPI, II and III. I showed that the deletion of a Saccharomycotina specific domain (SMS) from Trs23p prevents the TRAPP core from assembling, both in vitro and in 




Chapter 2: A trs20 mutation that mimics an SEDT-causing mutation blocks 
selective and non-selective autophagy: a model for TRAPPIII organization 
This Chapter was published as a manuscript in the journal Traffic (Brunet et al., 2013). I shared first authorship of this paper with Nassim Shahrzad and I am responsible for the following figures: Figure 2.4, 2.6(A &B), 2.7, 2.8, 2.10, 2.11, 2.12, 2.14(B), 2.15, 2.16, 2.17 and 2.18.  




TRAPPI is composed of six distinct polypeptides (Bet5p, Bet3p, Trs20p, Trs23p, Trs31p, Trs33p) although the levels of Trs20p appear to be sub-stoichiometric in this complex (Sacher et al., 2001). Two related complexes called TRAPPII and III have also been described (Sacher et al., 2001; Lynch-Day et al., 2010). Each complex contains the TRAPPI core along with unique polypeptides: Trs65p, Tca17p, Trs120p and Trs130p for TRAPPII, and Trs85p for TRAPPIII (Sacher et al., 2001; Montpetit and Conibear, 2009; Lynch-Day et 
al., 2010; Choi et al., 2011). TRAPPII has been implicated in traffic at the late Golgi, endocytosis and non-selective autophagy (Sacher et al., 2001; Cai et al., 2005; Zou et al., 2013) and TRAPPIII has been shown to function in selective autophagy (Meiling-Wesse et 
al., 2005; Lynch-Day et al., 2010; Lipatova et al., 2012). Interestingly, Trs85p, the TRAPPIII-specific subunit, has been implicated in ER-to-Golgi transport as well (Sacher et al., 2001; Zou et al., 2012b). Since the TRAPPI core possesses Ypt1p GEF activity, both TRAPPII and III have also been shown to be capable of activating Ypt1p (Sacher et al., 2001; Lynch-Day 




 While elegant, we speculated that the model put forth regarding the role of C2 in pro-collagen secretion may not explain the etiology of all SEDT mutations since yeast do not secrete collagen nor do they possess a readily identifiable homolog of the collagen receptor. Furthermore, C2-dependent Golgi fragmentation and collagen secretion are separable functions (Scrivens et al., 2009; Venditti et al., 2012) suggesting C2 may have several roles in the cell. Interestingly, an SEDT-causing missense mutation at D47 in C2 (C2D47Y) cannot suppress the lethality of a yeast trs20∆ mutation although wild type C2 can (Gecz et al., 2003). Since yeast do not produce collagen, this suggests that the D47 residue is involved in some other process. We therefore set out to characterize the interactions and function of the C2D47Y protein and its yeast homolog trs20D46Yp. Here we demonstrate an interaction between C2 and the SNARE protein Syntaxin 5 and show that this interaction is sensitive to the D47Y mutation. In yeast, trs20D46Yp is not involved in anterograde transport but is defective in endocytosis and both selective and non-selective autophagy, correlating with a destabilization of TRAPPIII. We also show that the appearance of TRAPPIII is dependent upon Atg9p and that the function of TRAPPIII is influenced by palmitoylation of Bet3p, suggesting unexpected complexities in TRAPPIII assembly and localization. 
 
2.2 Materials and methods 




2.2.2 Yeast two-hybrid analysis Yeast cells (AH109 and Y187) were transformed with either pGBKT7 or pGADT7 constructs. The cells were mated overnight on YPD plates and then replicated to selective medium (-leucine/-tryptophan, -leucine/-tryptophan/-histidine ± 2mM 3-aminotriazole, -leucine/-tryptophan/-histidine/-adenine) to ensure that both plasmids were present and to test for an interaction. Growth was monitored daily for up to 8 days.  
2.2.3 Cell culture and immunoprecipitation HeLa and 293T cells were maintained in a humidified environment with 5% CO2 at 37°C. Transfections were performed using the Ca2PO4 method and 10µg of plasmid DNA per 10cm dish. In certain cases cells were treated with 10µM N-ethylmaleimide (NEM) during the time course indicated in Figure 2.3. For immunoprecipitations, 500µg of lysate prepared in lysis buffer (150mM NaCl, 50mM Tris pH 7.2, 1mM DTT, 1% Triton X-100, 0.5mM EDTA, 1 mini-tablet of protease inhibitor cocktail (Roche) per 10mL) was incubated with 0.4µg of anti-Syntaxin 5 antibody (Santa Cruz) overnight on ice. The sample was then incubated with a 10µl bed volume of protein A-agarose beads for 60 minutes in the cold. The beads were washed 3 times with lysis buffer and eluted by boiling with 25µl SDS-PAGE sample buffer.  




acid on ice. The pellet was dissolved in SDS-PAGE sample buffer and fractionated by SDS-PAGE.  Calcofluor white (CFW) growth was monitored by spotting serial dilutions of cells on YPD ± 10µg/ml CFW and incubating the plates at 30°C. Growth was monitored daily for up to 5 days.  Processing of pre-Ape1p was performed by monitoring the forms of the protein using Western analysis (Klionsky et al., 1992). Cells were grown overnight to an OD600 ≤ 1 in YPD and resuspended in pre-warmed YPD medium at 37.5°C (for heat sensitive mutants) or 30°C for 1 hour. For selective autophagy cells were immediately processed for lysis (see below). For non-selective autophagy cells were pelleted, washed in water and re-suspended in pre-warmed synthetic medium lacking nitrogen, incubated for 2-4h at 37.5°C (for heat sensitive mutants) or 30°C, and then processed for lysis. Localization of GFP-Ape1p was performed on fixed cells according to the GFP-Snc1p protocol above. 
 
2.2.5 Preparation of yeast cell lysates Lysates for size exclusion chromatography were prepared as previously described (Brunet et al., 2012) and 2-5mg of total protein was fractionated on a Superose 6 column. In some cases 1% Triton X-100 was added to the lysis buffer and was included in the size exclusion column buffer. For pre-Ape1p processing, lysates were prepared by converting the cells to spheroplasts in medium containing 1.4M sorbitol, 50mM KPi pH 7.5, 36mM β-mercaptoethanol, 33µg/ml zymolyase 100T for 30 minutes at 37.5°C. Spheroplasts were lysed in 1% SDS, boiled and cleared by centrifugation.  




exclusion column buffer to a final volume of 300 µl and then loaded on top of a step Optiprep gradient composed of 1 ml 15%, 1 ml 30%, 1 ml 40%, 0.8 ml 45% and 1.2 ml 54% Optiprep. The sample was centrifuged in an SW55 rotor at 36,000 rpm for 16 hours. Fractions were collected from the top of the tube and probed for Trs85p-HA with anti-HA antibody. 
 
2.2.7 Recombinant protein expression and in vitro binding Syntaxin 5 (amino acids 1-333) was recombined into pDEST15 (GST fusion vector) from a Gateway entry clone. C2 and C2D47Y were recombined into pDEST17 (His fusion vector) from Gateway entry clones. Protein was expressed by inducing with 1mM IPTG in BL21(DE3) cells overnight at 25°C. The protein was purified on glutathione-agarose resin or Ni2+-NTA resin as per manufacturer’s instructions.  
In vitro binding assays contained 0.5µM of GST-Syntaxin 5 with increasing amounts (0, 0.1, 0.2, 0.5 µM) of His-tagged C2 wild type or D47Y. Samples were made up to a total volume of 250 µl with 1x binding buffer (10mM HEPES pH 7.4, 25mM NaCl, 115mM KCl, 2mM MgCl2, 0.1% Triton X-100) and left on ice at 4ºC for 1 hour to allow binding. Pulldown employed 10 µl glutathione agarose resin (GE Healthcare) in the cold for 1 hour. Samples were washed 3x with binding buffer and eluted by boiling with SDS-PAGE sample buffer. Western blotting was performed using HRP-conjugated anti-His antibody (Qiagen).  
2.2.8 Acyl-biotin exchange 
 Biotinylation of acylated proteins was performed essentially as described (Hou et 
al., 2005; Wan et al., 2007) with minor modifications. A wild type yeast lysate was prepared in the absence of detergent and fractionated on a Superose 6 column as described (Brunet 




4°C. The proteins were precipitated one time using methanol/chloroform, resuspended in PBS containing 0.1% Triton X-100 and incubated with 15µl of streptavidin-agarose beads (Sigma) for 1 hour at room temperature. The beads were washed in PBS containing 0.5M NaCl and 0.1% Triton X-100 after which the proteins were eluted by boiling in a 3:1 mix of buffer A: 4xSDS-PAGE sample buffer. Bet3p was detected by Western analysis using anti-Bet3p IgG.  
2.3 Results 
2.3.1 Binding of TRAPPC2 to Syntaxin 5 is dependent upon the D47 residue in 





Figure 2.1 TRAPPC2 binds to Syntaxin 5 by yeast two hybrid. (A) TRAPPC2 was cloned into the yeast two hybrid vector pGBKT7 and the SNAREs indicated were cloned into pGADT7. The plasmids were transformed into AH109 and Y187 cells, mated and spotted as serial dilutions onto SD-leu/-trp and SD-leu/-trp/-his/-ade and grown at 30°C for ~3 days. (B) Full length Syntaxin 5, the SNARE domain (amino acids 263-333) or the amino-terminal domain (amino acids 1-262) of Syntaxin 5 were cloned into pGADT7 and tested for an interaction by yeast two hybrid with TRAPPC2 (or an empty pGADT7 vector control) as described in (A). (C) TRAPPC2 in pGBKT7 was tested for its ability to interact with the indicated TRAPP proteins expressed in pGADT7 by yeast two hybrid. (D) TRAPPC2 or the indicated mutants were inserted into pGBKT7 and tested for their ability to interact with Syntaxin 5 cloned into pGADT7 by yeast two hybrid.  In order to confirm the interaction between C2 and Syntaxin 5, we performed in 




myc-C2. Consistent with the first two assays, we noted an interaction between Syntaxin 5 and C2 that was weakened by the D47Y mutation in C2 (Figure 2.2B).  
 





Figure 2.3 TRAPPC2 binds to SNARE complexes. (A) HeLa cells were transfected with myc-tagged TRAPPC2 or TRAPPC2D47Y and then treated for increasing times (indicated) with 10µM NEM. Lysates were prepared and Syntaxin 5 was immunoprecipitated as in Figure 2.2 B (lanes 2-5). Lysate in lane 1 was from a non-transfected culture. The bound, tagged TRAPPC2 was detected using anti-mycIgG and Syntaxin 5 was detected using anti-Syntaxin 5 IgG. A portion (10%) of the input is shown. (B) Non-transfected HeLa cells were treated for increasing times (indicated) with 10µM NEM. Lysates were prepared and processed as in (A). Lysate in lane 1 was not incubated with IgG during the precipitation and only received protein A-agarose beads. Endogenous TRAPPC2 was detected using anti-TRAPPC2 IgG. A portion (10%) of the input is shown.  
2.3.2 The yeast mutant trs20D46Y does not prevent processing of carboxypeptidase 
Y The human C2 D47 residue is conserved in the yeast Trs20 protein at D46. Since yeast do not secrete collagen, and since we failed to detect a similar interaction between Trs20p and the yeast Syntaxin 5 homolog Sed5p (not shown), this conserved residue must be involved in some other cellular process. To address this we studied the consequences of the equivalent mutation in TRS20 (trs20D46Y) in yeast. Although this mutant was slightly heat sensitive, it was not as severely-compromised as trs20ts, a mutant that was constructed by random mutagenesis (see Figure 2.6A). In order to investigate whether 




These results suggest that trs20D46Y does not function in ER-to-Golgi traffic but may affect some aspect of TRAPPII and/or III activity.  
 
Figure 2.4 trs20D46Y does not block trafficking of carboxypeptidase Y. Yeast strains indicated were pulsed with 35S-methionine for 4 minutes and chased with unlabeled methionine for the times indicated as described in materials and methods. Carboxypeptidase Y (CPY) was immunoprecipitated using anti-CPY IgG, and the forms of CPY were visualized by radioautography. 
 
2.3.3 The D46Y mutation in trs20 affects its interactions with TRAPPII and III 





Figure 2.5 The trs20D46Y mutation disrupts the interaction of Trs20p with TRAPPII 
and TRAPPIII specific subunits. The open reading frames encoding TRS20 and trs20D46Y were cloned into pGBKT7, transformed into AH109 yeast cells, and mated to Y187 yeast that harbored pGADT7 containing the indicated TRAPP open reading frames. The resulting diploids were spotted onto SD-leu/-trp (top panel) or SD-leu/-trp/-his (bottom panel).  We also used yeast genetic interactions to investigate the connection between 





Figure 2.6 Genetic interactions affected by trs20D46Y. (A) A yeast strain with 
trs20D46Y as the sole copy of TRS20 was spotted as a serial dilution on YPD plates and grown at either 30°C or 39°C. A trs20ts strain (Ben-Aroya et al., 2008)(56) was also included. The same trs20 mutations were introduced into a yeast strain with the sole copy of TRS130 tagged with the HA epitope. (B) The trs20D46Y mutation was introduced into a yeast strain in which the chromosomal copy of TRS65 (trs65∆) or TRS85 (trs85∆) was deleted and a copy of wild type TRS65 or TRS85 was maintained on aURA3-based plasmid. The plasmid was counter-selected on 5-fluoroorotic acid-containing plates. (C) A yeast strain (TRS130-HA trs20D46Y; see A) was transformed with a plasmid containing the indicated TRAPP gene and grown on YPD plates at either 30°C or 38.5°C. 
 
2.3.4 trs20D46Y phenocopies trs85∆ in both GFP-Snc1p recycling and Calcofluor 




supernatant was assayed for secreted proteins. As expected, sec18, a gene involved in virtually all membrane trafficking steps, potently blocked the appearance of secreted proteins compared to wild type (Figure 2.7). In contrast, trs20D46Y appeared similar to wild type, suggesting that secretion is not defective in this mutant. A similar result was seen for trs85∆ (Figure 2.7) whereas trs130ts showed a partial block in secretion (not shown; see (Cai et al., 2005)). A partial block in secretion was also seen in trs20ts (Figure 2.7). 
 





Figure 2.8 trs20D46Y and trs85∆ strains are sensitive to Calcofluor white. The indicated yeast strains were spotted as serial dilutions on YPD plates either with or without 10µg/ml Calcofluor white and grown at 30°C.  We next examined GFP-Snc1p localization in these cells. Snc1p is a SNARE protein that cycles between the Golgi and plasma membrane via the endocytic pathway. When fused to GFP, the protein localizes to the plasma membrane and to small buds in dividing cells (Figure 2.9). Previous studies have shown an accumulation of internal structures in 





Figure 2.9 The trs20D46Y mutant phenocopies the GFP-Snc1p recycling defect 
observed in trs85∆ cells.   Yeast strains were transformed with a plasmid containing GFP-Snc1p. The cells were fixed with paraformaldehyde and the localization of GFP-Snc1p was assessed by fluorescence microscopy. Accumulation of GFP-Snc1p on internal structures is seen in 24±1%, 62±2%, 77±1% and 89±3% of wild type, trs20ts, trs20D46Y and trs85∆ cells, respectively (N=150 for each strain, performed in triplicate). The scale bar is 5µm. 
 











Figure 2.11 TRAPPIII is destabilized in trs20D46Y. Lysates from the Trs85p-HA-tagged strains in Figure 2.10 were fractionated on a Superose 6 size exclusion column in 300mM NaCl and fractions were probed with (A) anti-Trs23p or (B) anti-HA (to detect Trs85p-HA) IgG. The location of the TRAPPI, II and III fractions are indicated as are the fractionation of molecular size standards.  




trs20ts (Figure 2.12). In the absence of nitrogen, when Ape1p is processed by non-selective autophagy, a significant amount of mature Ape1p was detected in trs20D46Y, trs20ts and 
trs85∆ with small amounts of the precursor form also present, suggesting a defect in non-selective autophagy (Figure 2.12, -N panel).  
 









2012a). Collectively, our results demonstrate that trs20D46Y affects both the selective (Cvt) and non-selective autophagic pathways without affecting anterograde transport.  





Figure 2.14 Tca17p is important for the integrity of TRAPPII but not TRAPPIII.(A) The open reading frame encoding TCA17 was cloned into pGBKT7, transformed into AH109 yeast cells, and mated to Y187 yeast that harbored pGADT7 containing the open reading frame for either TRS130, TRS120 or TRS85. Growth on SD-leu/-trp/-his/-ade indicates that Tca17p binds to only Trs130p. This Figure is related to Figure 2.5. (B) Lysate prepared from tca17∆ or trs85∆ was fractionated on a Superose 6 size exclusion column in 300mM NaCl. The peaks for TRAPPI, II and III are indicated. Also shown is the same wild type blot shown in Figure 2.11A for comparison. The Trs23p signal in the TRAPPII fractions is missing but remains in the TRAPPIII fractions.   




to II (Figure 2.15A). This spreading of the Trs23p peak in Triton X-100 was independent of Trs85p since a similar pattern was seen in trs85∆ treated with the detergent (Figure 2.15A). Such an effect was previously noted for Trs130p in a tca17∆ strain (Choi et al., 2011). Since Trs23p is absent from the TRAPPIII fractions in trs85∆ prepared without detergent (Figure 2.14B), this result suggests that the fractionation of Trs23p seen in the presence of Triton X-100 is likely due to changes to TRAPPII. Our results indicate that, in the absence of detergent, TRAPPIII is associated with Triton X-100-soluble membranes. Consistent with this notion, TRAPPIII penetrated an Optiprep gradient further in the absence, as compared to the presence, of Triton X-100 (Figure 2.15B).  
 




exclusion column. Our studies led us to focus on atg9∆. In whole cell lysates, the levels of Trs85p-HA, but not Trs23p, were dramatically reduced upon nitrogen starvation in 
atg9∆ compared to wild type (Figure 2.16A, compare +/- nitrogen). Correspondingly, there was a decrease in the appearance of Trs85p-HA in the TRAPPIII peak in nitrogen-starved 
atg9∆ cells relative to non-starved cells (Figure 2.16B). Remarkably, Trs23p was also reduced in the TRAPPIII fractions (Figure 2.16B). This result is similar to that seen for 





Figure 2.16 The molecular size of TRAPPIII is dependent upon Atg9p (A) Lysate in 300mM NaCl was prepared from wild type, atg9∆, atg17∆, atg9∆/TRS85-HA or 








2.3.9 Palmitoylated Bet3p is enriched in TRAPPIII TRAPPIII appears to be membrane associated while TRAPPI is more easily separated from membranes since fractionation of the latter on a size exclusion column is not affected by detergent. What can account for this difference? The TRAPPI core subunit Bet3p was shown to be lipid-modified by either palmitoylation or myristoylation (Kim et 
al., 2005; Turnbull et al., 2005). The modified cysteine residue at position 80 in the yeast protein is highly conserved yet, surprisingly, mutation of this residue does not lead to any observable growth phenotype. We speculated that lipid-modified Bet3p may partially account for the association of the TRAPPIII complex with PAS membranes. If this is the case, bet3C80S, a mutant that prevents Bet3p palmitoylation (Kim et al., 2005; Turnbull et 
al., 2005; Kummel et al., 2006), may block autophagy. Indeed, compared to wild type, 
bet3C80S displayed both a defect in Ape1p processing in the presence, but not the absence, of nitrogen and a starvation-induced reduction in GFP-Atg8p processing (Figure 2.17). In addition, bet3C80S also displayed an enlarged Ape1p-GFP punctum similar to that seen for 
trs85∆ and trs20D46Y (Figure 2.13). This suggests that palmitoylation of Bet3p is involved in the efficient functioning of TRAPPIII in both selective and non-selective autophagy.  
 




Given the results above we speculated that palmitoylated Bet3p would be enriched in TRAPPIII. To test this notion, a wild type lysate was fractionated by size exclusion chromatography and the fractions containing TRAPPI, II and III were pooled separately and subjected to acyl-biotin exchange. In this assay, acyl chains on proteins are exchanged for a biotin moiety which can then bind to streptavidin-agarose beads. Precipitation of proteins onto the beads indicates that the proteins were initially acylated. As shown in Figure 2.18, after normalization to Bet3p levels in the input, acylated Bet3p was greatly enriched in TRAPPIII. Our results suggest that acylated Bet3p is important for the function and/or localization of the TRAPPIII complex. 
 
Figure 2.18 Lipidated Bet3p is enriched in TRAPPIII. A wild type lysate was fractionated on a Superose 6 column and the peak of TRAPPI, II and III were pooled individually and subjected to acyl-biotin exchange as described in materials and methods. A portion of each input fraction, to enable normalization to Bet3p, along with the entire precipitate from the streptavidin-agarose beads was subjected to Western analysis using anti-Bet3p serum and quantitated using Image J. Error bars indicate standard deviation.  
2.4 Discussion Here we demonstrate that the mammalian TRAPP protein C2 binds to the SNARE protein Syntaxin 5. This interaction is weakened by the pathogenic D47Y mutation in C2 and led us to speculate that a yeast mutation patterned after this mutation in the C2 homolog Trs20p would affect early secretory pathway traffic. Instead this yeast mutant (trs20D46Y) did not display anterograde trafficking defects but was defective in the selective (Cvt) and non-selective autophagy pathways. In addition, trs20D46Y, atg9∆ and 




complex that is involved in these pathways. It should be stressed that, although the trs20 mutants examined in this study did not display trafficking defects in the early secretory pathway, other residues in this protein may in fact impinge on this process. 
 
2.4.1 Complexities in TRAPPIII assembly and function The subunit composition of TRAPPIII differs from TRAPPI by just a single additional protein (Trs85p in TRAPPIII), yet the molecular size of TRAPPIII is much greater than that of TRAPPI (see Figures 2.10, 2.11, 2.15, and 2.16) (Choi et al., 2011; Brunet et al., 2012) and this is not due to oligomerization of Trs85p/TRAPPIII (Choi et al., 2011) (S.B. and M.S., unpublished observation). We found that the cellular levels of the TRAPPIII-specific protein Trs85p-HA, but not the TRAPPI core protein Trs23p, were greatly diminished in trs20D46Y as well as in atg9∆, but unaffected in atg17∆ relative to wild type. The former two mutants showed reduced levels of both Trs85p-HA and Trs23p in the TRAPPIII fractions. Our results imply that, during non-selective autophagy, the recruitment of TRAPPIII to autophagic membranes is dependent upon Atg9p (Figure 2.19A). Our data do not address which, if any, subunit of TRAPPIII interacts directly with Atg9p. However, a recent report suggested that Trs85p, but not other TRAPPI core subunits, binds directly to Atg9p and its localization is affected in atg9∆ cells (Kakuta et al., 2012). If this is the case, our results with 









affected. A similar phenotype consisting of a mild defect of Ape1p processing but a strong defect in GFP-Atg8p processing in starvation conditions has been reported for the TRAPP mutant trs85∆ as well as for vac8∆ (Cheong et al., 2005; Meiling-Wesse et al., 2005; Zou et 
al., 2013). In the latter mutant, autophagic bodies were reduced in both number and size. Our results, therefore, suggest that in trs20D46Y Cvt vesicles fail to form. However, in nitrogen-starved conditions, while some autophagosomes may form, their size is likely to be abnormally small.  What is the role of Bet3p lipidation in TRAPPIII function? The enrichment of lipidated Bet3p in TRAPPIII and the fact that TRAPPIII remains membrane-associated in 
bet3C80S  (S.B. and M.S., unpublished observation), suggests that lipidation alone cannot account for TRAPPIII membrane attachment. It is tempting to speculate that lipidated Bet3p may localize the complex to a membrane sub-domain of authophagic vesicles. It is noteworthy that acylation of proteins is one mechanism that directs their intracellular localization (Roskoski Jr., 2003; Munro, 2005). Alternatively, lipidation of Bet3p/TRAPPC3 has been postulated to alter its structure (Turnbull et al., 2005; Kummel et al., 2006, 2010), which may promote binding to these specialized membrane regions or increase the efficiency of TRAPPIII function (Figure 2.19D).  




2010). While our results leave this possibility open, we do not believe this to be the case for the following reasons. The interaction between Trs20p and Trs130p is much weaker than that between Trs20p and Trs120p (M.S., unpublished observation). In addition, the similarity in structure between Trs20p and Tca17p leaves open the possibility that some Trs20p interactions occur due to the similar structure between these two proteins and do not take place in vivo. Indeed, Tca17p was found to bind only to Trs130p which is consistent with a previous study showing that Tca17p binds to the amino-terminus of Trs130p (Choi et al., 2011) and our earlier result showing a strong genetic interaction between TCA17 and TRS130 (Scrivens et al., 2009). We suggest that Tca17p may be the TRAPP subunit that interacts with Trs130p while Trs20p acts as an adaptor to allow either Trs85p or Trs120p to interact with the TRAPPI core complex. It remains unclear how Tca17p interacts with the TRAPPI core and how it is excluded from TRAPPIII.  




Chapter 3: The SMS domain of Trs23p is responsible for the in vitro 
appearance of the TRAPPI complex in Saccharomyces cerevisiae 
This Chapter was published as a manuscript in the journal Cellular Logistics (Brunet 
et al., 2012). I am responsible for all figures in this manuscript with the exception of Figure 3.1 (C & D) and Figure 3.12 (A).  




One of the earliest MTCs identified was the TRAPP complex (Sacher et al., 2001, 2008). Although this complex has not been demonstrated to tether two distinct membranes together, it is believed to accomplish this either directly or by leading to recruitment of the factor(s) that does this. In the yeast S. cerevisiae there are three forms of the complex called TRAPPI, II and III (Sacher et al., 1998, 2001; Cai et al., 2005; Lynch-Day et al., 2010). As such, TRAPP poses a unique set of problems with respect to the role of these complexes in determining specificity in this organism. All three complexes contain the same "core" of six polypeptides (Bet3p, Bet5p, Trs20p, Trs23p, Trs31p, Trs33p) with TRAPPII containing four additional subunits (Tca17p, Trs65p, Trs120p, Trs130p) and TRAPPIII containing one additional subunit (Trs85p). While TRAPPI has been implicated in ER-to-Golgi transport (Sacher et al., 1998, 2001), TRAPPII has been shown to function at a later Golgi compartment (Sacher et al., 2001; Cai et al., 2005) and TRAPPIII was suggested to function in autophagy (Meiling-Wesse et al., 2005; Nazarko et al., 2005; Lynch-Day et al., 2010). Confounding the problem of TRAPP-mediated specificity is the fact that Bet3p, a common subunit found in two copies within the core (Sacher et al., 2000; Kim et al., 2006; Cai et al., 2008), was shown to bind to Sec23p, a component of the ER-derived COP II coat (Cai et al., 2007b), suggesting that the Sec23p-binding site on all copies of Bet3p must be blocked in both TRAPPII and III. In addition, this core of the complex was shown to be sufficient for Ypt1-directed guanine nucleotide exchange factor (GEF) activity (Kim et al., 2006) and indeed all three complexes have been reported to be capable of such activity (Sacher et al., 1998, 2001; Jones et al., 2000; Wang et al., 2000; Lynch-Day et al., 2010). Finally, to date only one complex has been reported in mammalian cells and it was recently shown that this complex contains homologs of the S. cerevisiae TRAPPII- and III-specific proteins (Yamasaki et al., 2009; Choi et al., 2011; Scrivens et al., 2011).  In an effort to better understand the relationship between the TRAPP complexes, we focused on Trs23p that links two Bet3p-containing subcomplexes to form the TRAPP holocomplex (Kim et al., 2006; Cai et al., 2008), thus providing GEF activity. In addition, Trs23p interacts with the GTPase Ypt1p (Cai et al., 2008). Also unique to this subunit is a PDZ-like domain in higher eukaryotes and a Saccharomycotina-specific domain seen in the 




Furthermore, co-expression of the core proteins leads to assembly of a functional complex when using the S. cerevisiae proteins but the mammalian proteins fail to assemble (Kim et 
al., 2006), suggesting differences in the assembly and/or stability of the core between both organisms.  Using random and targeted mutagenesis we have constructed a series of mutations in Trs23p. We show that neither the carboxy-terminal 99 amino acids (trs23∆99C) nor the 













3.2 Materials and methods 
 
Table 3.1 Yeast strains used in Chapter 3. MSY20 MATa can100 leu2-3112 his3-11 trp1∆ ura3-1 ade2-1 MSY62 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15trs23∆::KanMX pRS316-TRS23 MSY107 MATαhis3Δ1 leu2Δ0 ura3Δ0MET15 trs23∆::KanMX pRS316-TRS23 pRS315-
trs23∆202C MSY109 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15trs23∆::KanMX pRS316-TRS23 pRS315-
trs23∆167C MSY118 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15trs23∆::KanMX pRS315-trs23Δ99C MSY119 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS315-TRS23 MSY243a MATαhis3Δ1leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316- trs23Δ99C MSY245 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::Neurseothricin pRS316-TRS23  MSY251 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316-TRS23 pRS315-
trs23MPR/AWS MSY297 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316-TRS23 pRS315- 
trs23ΔSMS MSY366 MATa trp1-901 leu2-3 112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1UAS-
GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ pGADT7-
BET5 MSY367 MATa trp1-901 leu2-3 112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1UAS-
GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ pGADT7-
TRS20 MSY370 MATa trp1-901 leu2-3 112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1UAS-
GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ pGADT7-
TRS31 MSY449 MATα ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 met- gal4∆ gal80∆ 
URA3::GAL1UAS-GAL1TATA-lacZ pGBKT7GTWY-TRS23 MSY450 MATα ura3-52 his3-200 ade2-101 trp1-901 leu2-3 112 met- gal4∆ gal80∆ 
URA3::GAL1UAS-GAL1TATA-lacZ pGBKT7GTWY- trs23ΔSMS MSY453 MATa trp1-901 leu2-3 112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1UAS-
GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-MEL1TATA-lacZ pGADT7 MSY458 MATα his3Δ1 leu2Δ0ura3Δ0MET15trs23∆::KanMX pRS315-trs23Δ99C pRS416-
GFP-SNC1  MSY459 MATα his3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS315-TRS23 pRS416-GFP-




MSY474 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX TRS130-3xHA::HIS3 pRS315- 
trs23Δ99C   MSY475 MATα his3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX TRS130-3xHA::HIS3 pRS315-
TRS23   MSY478 MATa can100 leu2-3112 his3-11 trp1∆ ura3-1 ade2-1 trs85∆::HIS3 pRS416-GFP-
SNC1 MSY485 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316- trs23Δ99C pRS315 
GFP-YPT31  MSY486 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316-TRS23 pRS315 -GFP-
YPT31 MSY531 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX TRS130-3xHA::HIS3 pRS315- 
trs23MPR/AWS MSY532 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX TRS130-3xHA::HIS3 pRS315-
trs23ΔSMS MSY545 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316-TRS23 pRS315-
trs23Δ15N MSY546 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15 trs23∆::KanMX pRS316-TRS23 pRS315- 
trs23∆109C MSY560 MATαhis3Δ1 leu2Δ0 ura3Δ0MET15 trs23∆::KanMX pRS315-trs23ΔSMS pRS416-
GFP-SNC1   MSY561 MATα his3Δ1 leu2Δ0 ura3Δ0MET15 trs23∆::KanMX pRS315-trs23ΔSMS TRS85-
3xHA::HIS3 MSY563 MATα his3Δ1 leu2Δ0 ura3Δ0MET15 trs23∆::KanMX pRS315-TRS23 TRS85-
3xHA::HIS3 MSY570 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15trs23∆::KanMX pRS315-TRS23pRS416-APE1-
GFP MSY572 MATαhis3Δ1 leu2Δ0 ura3Δ0 MET15trs23∆::KanMX pRS315-trs23ΔSMSpRS416- 
APE1-GFP MSY573 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 YDR108w(trs85∆)::KanMXpRS416- APE1-GFP MSY580 MATαhis3Δ1 leu2Δ0 ura3Δ0MET15 trs23∆::KanMX pRS316-trs23ΔSMS pRS315-








using the splicing by overlap extension PCR method or random mutagenesis. Mutant strains were created by plasmid shuffling using 5-fluoroorotic acid (5-FOA) counterselection. Endogenous TRS130 and TRS85 were tagged at the carboxy-terminus with a hemagglutinin (HA) epitope by genomic insertion of a cassette amplified from pFA6a-3HA-HIS3MX6 (Longtine et al., 1998). Insertion at the correct location was verified by PCR and Western blot analysis.  
3.2.2 Spotting Yeast strains were inoculated into 3 ml of minimal medium and grown in a shaker incubator overnight at 30°C. The OD600 was normalized to the lowest value and 10-fold serial dilutions were spotted onto minimal medium with 5-FOA or YPD (1% yeast extract, 2% peptone, 2% glucose). Yeast were placed at the permissive temperature of 30°C to serve as a growth control and at the restrictive temperatures of 16°C and 38°C. 
 
3.2.3 Preparation of yeast lysates For fractionation of yeast cytosols, cells were grown to mid log phase (OD600 of 1-1.5) overnight at 25°C. Cells were converted to spheroplasts as previously described (Kim 






3.2.4 Sucrose gradient fractionation and membrane floatation For equilibrium fractionation, the 16,000g pellet from 400 OD600 units of starting 
material was resuspended in 500 μl of 5% sucrose, Dounce homogenized and layered on top of a discontinuous sucrose gradient (1 ml each of 10%, 15%, 20%, 25%, 30%, 35%, 
40%, 45%, 50%, 55% and 500 μl of 60% sucrose). Gradients were centrifuged for 17 hours at 178,000g in an SW41Ti rotor at 4°C. Fractions of 500 µl were collected from top to bottom with a peristaltic pump.  For membrane floatation the 16,000gpellet from 400 OD600 units of starting 
material was resuspended in 500 μl of 60% sucrose and placed on the bottom of a centrifuge tube. A discontinuous step sucrose gradient was layered on top (1 ml each of 50%, 40%, 30%, 20% and 10% sucrose) and gradients were centrifuged for 4 hours at 178,000g in an SW55Ti rotor. Fractions of 500 μl were collected from top to bottom with a peristaltic pump. Sucrose solutions (w/w) were dissolved in 20mM HEPES pH 7.3.  
3.2.5 Membrane extraction The 16,000g pellet from approximately 70 OD600 units of starting material was resuspended to a final volume of 200 µl in lysis buffer (see above) or lysis buffer with either 1% Triton X-100, 0.5M NaCl, 0.1M Na2CO3 pH 11.0 or 5M urea, Dounce homogenized and incubated on ice for 30 minutes. Samples were centrifuged at 16,000g in a microcentrifuge for 10 minutes at 4°C. A volume of 100 µl of supernatant was added to 100 
µl of 2X Laemmli sample buffer and the pellet was resuspended in 200 µl of 1X sample buffer. 
 




Concentrated AKTA fractions for guanine nucleotide exchange factor assays (see below) were prepared by fractionating 20mg of total protein from a 21,000g supernatant (10mg at a time) and fractions were concentrated using a Millipore Amicon centrifugal filter to a final volume of 200 µl. Gel filtration buffer contained 150mM NaCl.  Samples were injected onto either a Superose 6 or a Superdex 200 column (GE Healthcare) connected to an AKTA liquid chromatography system. Fractions of 0.5 ml were collected and re-suspended in Laemmli sample buffer, fractionated by SDS-PAGE and analyzed by Western blotting. Endogenous Trs33p, Bet3p and Trs23p were detected using polyclonal antibodies raised in rabbits, the HA epitope was detected using a commercially available monoclonal antibody (HA.7, Sigma), the myc epitope was detected using the monoclonal antibody 9E10 and the TAP tag was detected with anti-TAP antibody (OpenBiosystems).  
3.2.7 Recombinant protein Yeast TRAPP subunits were expressed and purified from E. coliBL21(DE3) cells as previously described (Kim et al., 2006). Bet3p and Trs33p subunits were 6xHis-tagged and complexes were purified using Ni2+-NTA (Qiagen) followed by size-exclusion chromatography on a Superdex 200 column.  
3.4.8 Bacterial lysates Yeast TRAPP subunits were expressed in E. coli BL21 (DE3) cells as for recombinant protein (see above). Cells were sonicated in lysis buffer (20mM HEPES pH 7.3, 1mM DTT) and the lysates were clarified by centrifugation at 30,000g in aJA25.50 rotor (Beckman)prior to their use in guanine nucleotide exchange factor assays.  




(DE3) lysate was added to a final concentration of 4mg/ml. The zero minute time point for each sample was taken immediately after the pre-loaded Rab was added and 18 µl was removed for each subsequent time point.  Percent 3H-GDP remaining was based on the individual zero for each sample.   




The in vitro reconstituted ER-to-Golgi assay using purified proteins was performed as described (Barlowe, 1997).  Maturation of Ape1p-GFP was performed by first transforming the plasmid into yeast. The cells were then grown overnight to early log phase in minimal medium lacking uracil at which point they were converted to spheroplasts and lysed in 20mM HEPES, pH 7.3, 100mM NaCl, 0.1mM DTT, 2mM EDTA with protease inhibitors. Equal amounts of protein were fractionated by SDS-PAGE, transferred to PVDF membrane and probed with mouse anti-GFP (Roche). Quantitation was performed using Image J freeware.  
3.2.11 Yeast two-hybrid assay 
 TRS23 and variants of this protein were cloned into a Gateway®-modified pGBKT7 vector (pGBKT7GTWY) (Scrivens et al., 2011). All other TRAPP subunits were cloned into the pGADT7 vector by restriction enzyme cloning. Mating and analysis were as described by Scrivens et al. (2011).  
3.2.12 Chemical crosslinking  Fractionated samples in gel filtration buffer (50mM NaCl) were treated with 2mM dithiobis[succinimidyl] propionate (DSP) for 3 hours on ice. The reaction was quenched by adding Tris pH 7.5 to a final concentration of 20mM and incubating at room temperature for 15 minutes. For immunoprecipitation, the sample was diluted with gel filtration buffer (100mM NaCl) containing 1% Triton X-100 and incubated with 2µg IgG overnight on ice. The next day, immune complexes were collected on protein A beads, washed with lysis buffer and processed for Western analysis. In some experiments the crosslinked samples were re-fractionated on a Superose 6 column as described above.  
3.3 Results 
3.3.1 Neither the carboxy-terminal 99 residues nor the SMS domain of Trs23p are 








is not clear, the phenotype we now show is consistent with the non-essential nature of the carboxy-terminus of TRS23.  
 
Figure 3.1 Growth properties of trs23 mutations. (A) MSY62 was transformed with a plasmid (pRS315) containing TRS23 that was subjected to either random mutagenesis yielding nonsense mutations after the 17th, 52nd and 120th amino acids (trs23∆202C, 









Figure 3.2 Assembly and function of recombinant TRAPP containing the trs23∆99C 













Figure 3.3 The SMS domain of Trs23p contributes to the strength of Trs23p-TRAPP 
subunit interactions. (A) Wild type Trs23p or the mutants trs23∆99C and trs23∆SMS were expressed in yeast as fusion proteins with the DNA binding domain of Gal4p and mated to yeast strains expressing other TRAPP subunits fused to the transcriptional activation domain of Gal4p. Serial 10-fold dilutions of diploids were plated on SD-leucine/tryptophan, SD-leucine/tryptophan/histidine, SD-leucine/tryptophan/adenine and SD-leucine/tryptophan/histidine containing 5mM 3AT and all plates were incubated at 30°C. A two-dimensional schematic of the TRAPPII complex is shown adjacent to the panel. Shaded in gray is the TRAPPI core of the complex whose crystal structure and organization are known. The position and interactions of the remaining subunits (stippled) are not known but are based on previously published studies on the organization of yeast and mammalian TRAPP complexes (Montpetit and Conibear, 2009; Scrivens et al., 2009; Yip et 
al., 2010). (B) Lysates were produced from yeast cells expressing Trs23p, or the mutant proteins trs23∆SMS or trs23∆99C from the plasmid pGBKT7. Equal amounts of protein were loaded in each lane and probed with anti-myc IgG since the fusion proteins contain a 
myc epitope tag. Identical results were obtained when the blot was probed with anti-Trs23p IgG (not shown).  




Furthermore, the stability of TRAPP appears to be largely unaffected in trs23∆SMS, in contrast to trs23∆99C where several subunits are less stable (Figure 3.4B). Reduced levels of TRAPP could account for the growth phenotype seen for trs23∆99C. For these reasons, we focused our attention on the trs23∆SMS mutant which, although has weakened interactions, displays no defects in growth, TRAPP subunit levels or GEF activity in yeast. 
 
Figure 3.4 GEF activity is unaffected in S. cerevisiae containingtrs23∆SMS. (A) Lysates from yeast cells expressing wild type Trs23p (■) or the mutant proteins trs23∆99C (●), trs23∆SMS (○) or trs23MPR/AWS (X) were prepared and assayed for Ypt1p-directed GEF activity as described in Experimental Procedures. The intrinsic ability of Ypt1p to release nucleotide is also shown (▲). Assay represents three replicates and error bars represent ± SEM. (B) Lysates from wild type (lane 1), trs23MPR/AWS (lane 2), trs23∆SMS (lane 3) and 
trs23∆99C (lane 4) were probed with antibodies recognizing the TRAPP subunits indicated or anti-HA to detect endogenously-tagged Trs130p. Tubulin served as a loading control.  













Figure 3.5 A single TRAPP peak is detected in trs23∆SMS at physiological salt 
concentrations. (A) Lysates from wild type and trs23∆SMS were fractionated on a Superose 6 size exclusion column in buffer containing either 150mM NaCl or 300mM NaCl as indicated. Fractions of 0.5ml were collected and probed with antibodies that recognize Bet3p, Trs33p, Trs23p or HA (to detect endogenously-tagged Trs130p or Trs85p). I, II and III above the wild type and trs23∆SMS blots indicate the location of TRAPPI, II and III, respectively, under conditions where they separate from each other. Molecular size standards are also indicated above the blots. Note that a cross-reactive band appears just above the Trs33p band in fractions 32-34 with the anti-Trs33p antibody and the dash to the right of the Trs33 panels indicates the position of Trs33p. For each subunit shown, samples ranging from fractions 14-38 were fractionated on two separate polyacrylamide gels and processed for Western analysis simultaneously. Exposures for each half of the two gels were identical. (B) The signals for Trs33p (top panel) and Trs23p (bottom panel) from wild type (green) and trs23∆SMS (blue) at 150mM NaCl shown in (A) were quantitated using Image J and plotted as a percentage of the total signal. Note the absence of the TRAPPI peak in trs23∆SMS. (C) Lysates were prepared for fractionation as in (A) at either 150mM or 300mM NaCl. Samples before the centrifugation (T), the pellet fraction following centrifugation (P) and the supernatant (S) that was loaded onto the Superose 6 column were probed for Trs23p in both wild type and trs23∆SMS.   The fact that Trs85p and Trs130p co-fractionated in a single peak at physiological salt in both wild type and trs23∆SMS led us to consider the possibility that there is a single TRAPP complex that is unstable and easily fragments with increasing salt. Alternatively, these two TRAPP complexes could be either oligomerized or bound to other cellular components causing them to co-fractionate. To distinguish between these possibilities we constructed a strain that contains TAP-tagged Trs85p and Trs130p-myc. The strain was fractionated under conditions where only the TRAPPIII peak, but not the TRAPPII peak, was detected (50mM NaCl; see Figure 3.13A). The TRAPPIII-containing fraction was then treated with the crosslinking reagent DSP or left untreated before processing for immunoprecipitation. Although crosslinking was efficient (see Figure 3.13B), when Trs85p was immunoprecipitated with anti-TAP IgG we failed to detect co-precipitation of Trs130p-





Figure 3.6 TRAPPII and TRAPPIII are distinct complexes. Lysate from wild type cells containing Trs85p-TAP and Trs130p-myc were fractionated on a Superose 6 column and fractions 16-17 were collected and split in two. One sample was treated with DMSO while the other sample was treated with the crosslinking reagent DSP for 3 hours on ice. Each sample was then split in two and either treated with (+) or without (-) anti-TAP IgG. The immune complexes were collected on protein A-sepharose beads, fractionated by SDS-PAGE and probed with anti-myc IgG. Samples representing 10% of the input are shown.  
3.3.6 TRAPPII/III provides Ypt1p GEF activity in trs23∆SMS The ability of TRAPPI to act as a GEF for Ypt1p is firmly established (Jones et al., 2000; Sacher et al., 2001; Kim et al., 2006; Morozova et al., 2006; Cai et al., 2008). The absence of TRAPPI in trs23∆SMS along with near wild type levels of GEF activity in vivo, suggested that an alternate Ypt1p GEF was functioning to support ER-to-Golgi transport. One possibility is that Dss4p, a protein that facilitates nucleotide release from several GTPases including Ypt1p (Esters et al., 2001) and genetically interacts with TRAPP (Jiang et 
al., 1998), can facilitate nucleotide exchange on Ypt1p in the absence of TRAPPI. If this were the case, we would expect to see a genetic interaction between DSS4 and TRS23. Since 




lysates were assayed for GEF activity has been controversial (Jones et al., 2000; Sacher et 
al., 2001; Morozova et al., 2006; Cai et al., 2008). Yeast lysates from wild type and 
trs23∆SMS were fractionated by size exclusion chromatography on a Superose 6 column and fractions 16-17 (TRAPPII/III) and 29-31 (where TRAPPI fractionates) were assayed for Ypt1p GEF activity. Indeed, both the TRAPPII/III- and TRAPPI-containing fractions displayed Ypt1p GEF activity in wild type. In contrast, and consistent with the absence of TRAPPI in trs23∆SMS, this mutant only displayed Ypt1p GEF activity in the TRAPPII/III fractions (Figure 3.7). It is noteworthy that although TRAPPIII has been reported to display Ypt1p GEF activity (Lynch-Day et al., 2010), the Trs85p peak near TRAPPI is not active in our assay, suggesting that only the high molecular weight peak of Trs85p possesses this activity. Our results suggest that in the absence of TRAPPI, either TRAPPII or III can provide sufficient Ypt1p GEF activity to maintain cell growth. 
 
Figure 3.7 Only fractions containing TRAPPII/III display Ypt1p GEF activity in 
trs23∆SMS. Lysate from wild type (■) or trs23∆SMS (○) was fractionated by size exclusion chromatography on a Superose 6 column in 150mM salt. The fractions enriched in TRAPPII/III (fractions 16-17) and TRAPPI (fractions 29-31) were pooled, concentrated and assayed for Ypt1p GEF activity compared to the intrinsic ability of Ypt1p to release nucleotide. The intrinsic ability of Ypt1p to release nucleotide is also shown (▲). Assays represent three replicates and error bars represent ± SEM.  




carboxypeptidase Y (CPY) by pulse-chase analysis. This protein has ER (p1), Golgi (p2) and vacuolar (m) forms that are easily distinguished by SDS-PAGE. As shown in Figure 3.8, 
trs23∆SMS did not show a noticeable defect in CPY processing. The pattern was similar to wild type and stood in stark contrast to that of sec18 which displayed the expected block in ER-to-Golgi traffic as evidenced by the failure of the cells to process p1CPY.  
 
Figure 3.8 CPY trafficking is unaffected in the trs23∆SMS mutant. (A) Wild type, 





Figure 3.9 Snc1p recycling is unaffected in the trs23∆SMS mutant. Wild type, 





Figure 3.10 Ypt31p is correctly localized in the trs23∆SMS mutant.  Wild type, 
trs23∆SMS and trs23∆99C were transformed with a plasmid expressing Ypt31p-GFP. The cells were fixed and viewed using an epifluorescence microscope. For quantitation a minimum of 100 cells from three replicates were counted. The error bars represent ± SEM and representative cells used for quantitation are shown as insets.   TRAPPIII has recently been reported to function in autophagy (Lynch-Day et al., 2010). We therefore examined the cytosol-to-vacuole targeting (Cvt) pathway in 
trs23∆SMS using the marker Ape1p-GFP. This protein is processed by the Cvt pathway and is ultimately cleaved releasing GFP which is detected by Western analysis (Shintani et al., 2002). As shown in Figure 3.11, both wild type and trs23∆SMS were capable of processing Ape1p-GFP. In contrast, and as previously reported (Meiling-Wesse et al., 2005; Nazarko et 





Figure 3.11 The Cvt pathway is normal in the trs23∆SMS mutant. Wild type, trs23∆SMS and trs85∆ were transformed with a plasmid expressing Ape1p-GFP, grown in minimal medium without uracil, converted to spheroplasts and lysed. Samples were fractionated by SDS-PAGE and probed with anti-GFP. The percentage of Ape1p-GFP processing, calculated using Image J, is indicated below each lane.   We also examined trs23∆SMS for defects in an in vitro assay that reconstitutes ER-to-Golgi transport (Barlowe, 1997). This assay measures the acquisition of Golgi-specific modifications of a marker protein called pro-α-factor. Compared to wild type, trs23∆SMS did not show a defect in transport in vitro (Figure 3.12A). As was shown earlier using physiological salt (see Figure 3.5A), lysates from trs23∆SMS prepared in the buffer used for the in vitro assay (buffer B88) also showed a single TRAPP peak corresponding to TRAPPII/III (Figure 3.12B). Interestingly, lysates from wild type used for this assay showed a broadening of the TRAPPI peak suggesting this complex is not stable in this buffer. Collectively, our results suggest that trs23∆SMS does not adversely affect membrane traffic 





Figure 3.12 Lysates from the trs23∆SMS mutant are competent for In vitro ER-to-
Golgi trafficking.  Reconstitution of ER-to-Golgi traffic was performed as described in Experimental Procedures. Reactions were performed with no additions either on ice (ice) or at 29°C (NA), or fully reconstituted at 29°C (Recon). The results are expressed as percentage of concanavalin A-precipitable pro-α-factor that has received α-1,6-mannose Golgi modifications. The results are the average of duplicates and the range of transport over three independent experiments was 13.6%-15.4% (wild type) and 12.6%-14% (trs23∆SMS). (B) Lysates were prepared from wild type and trs23∆SMS in buffer B88 that was used for the in vitro transport assay in (A) and fractioned on a Superose 6 column in B88. Fractions were probed with anti-Trs33p. I, II and III above the blots indicate the location of TRAPPI, II and III, respectively, under conditions where they separate from each other.   




(Figure 3.13A). We then incubated this fraction either with or without the crosslinking reagent DSP and fractionated the sample in 300mM salt, conditions where all three TRAPP complexes are detected (see Figure 3.5A). As shown in Figure 3.13B, while the untreated sample did indeed show a TRAPPI peak, the crosslinked sample did not. Importantly, no intermediate peak between TRAPPII/III and TRAPPI was detected in the untreated sample. These results suggest that TRAPPI is a subcomplex of one or both of the larger (TRAPPII and III) complexes that forms in the presence of increasing salt in vitro.  
 





3.3.9 TRAPPI appearance is SMS domain-dependent TRAPPI, as defined by the co-fractionation of the TRAPP core subunits on a gel filtration column, is readily seen in S. cerevisiae but not in human cells (Menon et al., 2006; Scrivens et al., 2009, 2011; Yamasaki et al., 2009). We speculated that this may be due to added stability afforded to this complex by the SMS domain of Trs23p. Like the human protein, Trs23p in other yeast such as P. pastoris do not have the SMS domain. Thus, if our hypothesis is correct, we would expect that P. pastoris would not display a TRAPPI peak. We found that our antibody raised against the human TRAPPC3 protein, the most conserved subunit in TRAPP, was cross-reactive with P. pastoris Bet3p providing us with a means to address whether this yeast has a TRAPPI peak. Lysate from P. pastoris and S. 
cerevisiae was fractionated by size exclusion chromatography on a Superdex 200 column to better resolve the smaller molecular size region where TRAPPI fractionates. In S. cerevisiae, TRAPPI is detected in fraction 13 while TRAPPII/III is detected in fractions 8-9 (Figure 3.14). In the P. pastoris lysate, a high molecular weight pool of Bet3p was detected that most likely corresponds to TRAPPII/III (Figure 3.14). Based on the size of the P. pastoris TRAPP subunits, a TRAPPI complex would be expected to be only 30kD smaller than the S. 
cerevisiae complex. While a second peak of Bet3p was detected, it eluted in a fraction (fraction 17) with a molecular size much smaller than that expected for TRAPPI and no other peak of P. pastoris Bet3p was seen. The absence of a TRAPPI-equivalent was also noted for human cells, whose Trs23p homolog does not contain an SMS domain (Loh et al., 2005; Scrivens et al., 2009, 2011; Yamasaki et al., 2009). This result is consistent with the notion that the SMS domain of Trs23p stabilizes S. cerevisiae TRAPPI. 
 
Figure 3.14 P. pastoris does not contain a TRAPPI peak. Lysates in 150mM NaCl from P. 





3.4 Discussion Here we demonstrate that the Saccharomycotina-specific (SMS) domain of S. 
cerevisiae Trs23p is not required for Ypt1p-directed GEF activity but is important for the stable interaction between Trs23p and other TRAPP subunits. Our data suggest that cells devoid of this domain of Trs23p contain two large TRAPP complexes called TRAPPII and III and do not contain the smaller TRAPPI complex. These cells resemble wild type with respect to four different membrane trafficking assays both in vivo and in vitro and in terms of their growth characteristics. Based on our study, we suggest that the SMS domain of Trs23p stabilizes fragments (TRAPPI) of TRAPPII and/or III.  Collectively, our data may suggest that S. cerevisiae contain a single Golgi-localized TRAPP complex (TRAPPII) that is capable of supporting ER-to-Golgi traffic. This is based on a number of observations including: (i) removal of the SMS domain of Trs23p in S. 




subunits may be present in the complex. An alternative explanation for our data is that in the trs23∆SMS cells, TRAPPI is more tightly associated with the TRAPP superstructures and would require higher salt to be liberated. We do not favour this possibility since increasing the salt concentration in trs23∆SMS redistributes TRAPP core proteins from the higher molecular size fractions to a smaller fraction. The resulting peak is significantly smaller than TRAPPI and, at physiological salt, is devoid of Trs23p. It is evident that data addressing the existence and function of TRAPPI (which has only been demonstrated in 
vitro) as an independent TRAPP complex must be cautiously interpreted in light of our in 




architecture of TRAPPII (Yip et al., 2010). The notion that TRAPPI results from TRAPPII/III is analogous to a recent study that suggested that there were two Trs85p peaks on a size exclusion column (confirmed in the present study), where the low molecular weight peak may represent a breakdown product or an assembly intermediate of the higher molecular weight TRAPPIII peak (Choi et al., 2011).  If our suggestion of TRAPPI being an in vitro, salt-dependent fragment of TRAPPII/III is correct, this has strong implications for the role of tethering factors as determinants of specificity and for the mechanism of action of TRAPPIn ER-to-Golgi traffic in particular. The Golgi would in fact have a single TRAPP complex (TRAPPII) that could function in traffic at both ends of the organelle. In mammalian cells the early secretory pathway is more complex with a pre-Golgi ERGIC compartment (Schweizer et al., 1990) and the need to transport diverse-sized cargo (Schmidt and Stephens, 2010). Whether the mammalian TRAPP complex functions at both ends of the Golgi is still unknown. However, it has been shown to function in the early secretory pathway (Loh et al., 2005; Yu et al., 2006; Scrivens et al., 2009, 2011; Yamasaki et al., 2009) and only a single complex containing all S. cerevisiae TRAPP subunit homologs has been reported, suggesting that if mammalian TRAPP does indeed function at the late Golgi then a single complex would be expected to perform both of these functions. Indeed, parallels between S. cerevisiae and human TRAPP proteins with respect to their interactions with vesicle coat proteins have already been made (Cai et al., 2005, 2007b; Yamasaki et al., 2009). We suggest that factors on the vesicles (e.g. GTPases and SNAREs) in combination with coat proteins and tethers contribute to the overall specificity of vesicle transport. This notion helps to explain why some GTPases such as Ypt1p can function at multiple steps in membrane traffic (Bacon et 








Chapter 4: TRAPPII mediates Ypt6p dynamics at the late Golgi 
This Chapter is unpublished. I am responsible for the following all figures presented in this Chapter. 
 
4.1. Introduction Vesicles containing lipids and protein cargo are transported throughout the cell in a highly regulated manner in a process called membrane trafficking. (Palade, 1975; Novick et 
al., 1980; Balch et al., 1994).  Several factors cooperate to ensure that vesicles arrive at the correct compartment, among them small Rab GTPases and tethering factors (Bonifacino and Glick, 2004; Cai et al., 2007a). A number of different Rabs and tethering factors are located throughout the endomembrane system. Rabs act as molecular switches to activate or inactivate membrane trafficking pathways while tethers act to physically anchor vesicles to a specific target membrane (Zerial and McBride, 2001; Seabra and Wasmeier, 2004; Yu and Hughson, 2010).   Different proteins or complexes act as guanine nucleotide exchange factors (GEFs) to activate specific Rabs by inducing conformational changes that promote the loss of GDP and the uptake of GTP while GTPase accelerating proteins (GAPs) inactivate Rabs by accelerating their intrinsic rate of GTP hydrolysis (Bourne et al., 1990; Bos et al., 2007; Barr and Lambright, 2010). The coordinated recruitment of Rabs and their modifier proteins (GEFs and GAPs) to specific intracellular locations regulates the initiation and termination of membrane trafficking pathways. Rab GEF and Rab GAP cascades have been proposed to proceed in opposite directions and mediate sequential Rab activation and inactivation, respectively (Nottingham and Pfeffer, 2009). Each Rab within these cascades recruits the GEF for the next Rab and the GAP for the previous Rab in the pathway, providing directionality and limiting the localization of Rabs to specific compartments. Examples of these cascades have been described in secretory and endosomal trafficking pathways (Ortiz et al., 2002; Wang and Ferro-Novick, 2002; Rivera-Molina and Novick, 2009; Suda et 




ethylmaleimide-sensitive factor attachment protein receptor)(Barr, 2013).In contrast, aside from their interaction with Rabs, very few factors have been identified that mediate the recruitment of Rab GAPs to specific compartments. Rab GEFs are interesting candidates to promote Rab GAP recruitment to the correct location as they are diverse in their structure and composition and are directly involved in Rab activation. A GEF-GAP interaction could also create cross-talk between opposing Rab GAP and Rab GEF cascades, providing an additional layer of control to ensure that Rabs are turned “on” and “off” in a coordinated manner.   Ypt6p is a non-essential Rab in yeast that is implicated in several trafficking pathways including post-Golgi trafficking, endosome to Golgi transport, retrograde transport through the Golgi, ER to early Golgi transport, early Golgi to ER transport, and autophagy (Bensen et al., 2001; Luo and Gallwitz, 2003; Liu et al., 2006; Ohashi and Munro, 2010; Benjamin et al., 2011). Ypt6p is activated by the heterodimeric Ric1p/Rgp1p complex, and inactivated by the GAP protein Gyp6p (Strom et al., 1993; Siniossoglou et al., 2000; Will and Gallwitz, 2001). The GAPs Gyp2p and Gyp3p have also exhibited activity towards Ypt6p in vitro (Albert and Gallwitz, 1999). Like Ypt6p, Ric1p, Rgp1p and Gyp6p are all not essential for cell viability (Strom et al., 1993; Siniossoglou et al., 2000).   A Rab GAP cascade was recently described involving the recruitment of Gyp6p by active Ypt31/Ypt32p, a redundant Rab pair localized to the late Golgi, to promote the dissociation of Ypt6p from these membranes (Suda et al., 2013). The multisubunit tethering complex (MTC) TRAPPII acts as a GEF for the early Golgi Rab Ypt1p as well as a putative GEF for the Ypt31/32p Rab pair (Jones et al., 2000; Wang et al., 2000; Morozova et 




Gyp6p and causes Ypt6p to become enriched at the late Golgi, a phenotype also observed in a gyp6∆ mutant.  The interaction between TRAPPII, a Ypt1p and putative Ypt31/32p GEF, and the Rab GAP Gyp6p, is a novel mechanism for the recruitment of a GAP to the appropriate membrane and may also be an example of cross talk between a Rab GAP and Rab GEF cascade.  
4.2 Materials and methods 
Table 4.1 Plasmids used in Chapter 4. MSB238 pRS425  MSB247 pRS425-BET5  
MSB248 pRS425-TRS20  
MSB281 pRS425-TRS23  
MSB290 pRS425-BET3  MSB271 pRS425-TRS31  MSB250 pRS425-TRS33  MSB473 pRS425-TCA17  MSB291 pRS425-TRS65  MSB284 pRS425-TRS85  MSB285 pRS425-TRS120  MSB474 pRS425-TRS130  MSB1063 pRS315-GFP-YPT6 Received from Ruth Collins (RCB650) MSB1319 pRS316-ADH1pr-SEC7-mRFP Received from Akihiko Nakano(Suda et al., 2013) MSB1321 pRS306-ADH1pr-mRuby-
SED5 
Received from Akihiko Nakano (Suda et al., 2013) 
 
 
Table 4.2 Yeast strains used in Chapter 4. MSY135 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 MSY540 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ypt6∆::KanMX  
MSY609 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ric1∆::KanMX  




MSY772 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs65∆::KanMX pRS315-GFP-YPT6 MSY775 MATαhis3∆1 leu2∆0 lys2∆0 ura3∆0 ric1∆::KanMX pRS315-GFP-YPT6 MSY776 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 gyp6∆::KanMX pRS315-GFP-YPT6 MSY777 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pRS315-GFP-Ypt6 pRS316-ADH1pr-SEC7-
mRFP MSY778 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs65∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP MSY779 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 YEL048c∆::KanMX pRS315-GFP-YPT6 
pRS316-ADH1pr-SEC7-mRFP MSY781 MATαhis3∆1 leu2∆0 lys2∆0 ura3∆0 ric1∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP MSY782 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 gyp6∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP MSY806 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs85∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP MSY786 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 pRS315-GFP-YPT6pRS306-ADH1pr-mRuby-
SED5 MSY787 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs65∆::KanMX pRS315-GFP-YPT6pRS306-
ADH1pr-mRuby-SED5 MSY790 MATαhis3∆1 leu2∆0 lys2∆0 ura3∆0 gyp6∆::KanMX pRS315-GFP-YPT6pRS306-
ADH1pr-mRuby-SED5 MSY800 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs65∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP pRS313 MSY801 MATαhis3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 trs65∆::KanMX pRS315-GFP-YPT6pRS316-
ADH1pr-SEC7-mRFP pRS313-TRS65 
MSY366 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
BET5 
MSY367 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS20 
MSY368 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
BET3 
MSY369 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS23 
MSY370 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS31 
MSY371 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS33 






MSY373 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS85 
MSY374 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS120 
MSY375 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TRS130 
MSY376 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7-
TCA17 
MSY377 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZpGADT7 
MSY538 MATα, ura3-52, his3-200, ade2-101, trp1-901, leu2-3, 112, met-, gal4D, gal80D, 
URA3::GAL1UAS-GAL1TATA-lacZ pGBKT7(gateway modified)-GYP6 
 
4.2.1 Strain construction In wild type and mutant strains GYP6 was tagged at the carboxy terminus with a hemagglutinin (HA) epitope by genomic insertion of a cassette amplified from pFA6a-3HA-
His3MX6 (Longtine et al., 1998). Insertion at the correct location was verified by PCR and Western blot.  
 




one time with 200µL of TEV-C buffer with 5µg/mL of recombinant TEV protease. Beads were then incubated with 1mL of TEV-C buffer with 5µg/mL of recombinant TEV protease and for 2h at 16°C while nutating.  The eluate combined with two 1mL TEV-C buffer washes was transferred to a new polyprep column and the following was added: 6mL of CAM-B buffer (10mM Tris-HCl pH 8.0/100mM NaCl/0.1% CHAPS/1mM MgOAc2/1mM imidazole/2mM CaCl2/5% glycerol/10mM β-mercaptoethanol), 9µL of 1M CaCl2, and 250µL of a 50% slurry of calmodulin beads. The mixture was nutated for 2h at 4°C and the beads were washed 3 times with 1.5mL of CAM-B buffer. The beads were incubated with 250µL of CAM-E buffer (10mM Tris-HCl pH 8.0/100mM NaCl/0.1% CHAPS/1mM MgOAc2/1mM imidazole/10mM EGTA/5% glycerol) for 5 min and eluate was collected. A total of five fractions were collected, pooled and TCA precipitated. The total amount of precipitated protein was resuspended in sample buffer and loaded onto an SDS-PAGE gel. Peptides were extracted from gel slices and injected into an LTQ-Orbitrap Velos ETD mass spectrometer. Data was analyzed using SEAQUEST software. 
 




4.2.4 Serial dilutions Yeast strains were inoculated into 3mL of minimal medium and grown in a shaker incubator overnight at 30°C. The OD600 was normalized to the lowest value and 10-fold serial dilutions were spotted (2µL) onto minimal selective medium. Yeast were placed at the permissive temperature of 30°C to serve as a growth control and at the restrictive temperatures of 37°C.  
 
4.2.5 Microscopy and Quantification of microscopy Yeast strains were inoculated into 3mL of minimal medium and grown overnight at 30°C to log phase.  Cells were pelleted and resuspended in fresh medium to an OD600 of 10-15 and visualized on a Nikon Eclipze TiE inverted epifluorescence microscope using a 100x objective. Images were deconvoluted using AutoQuant X3 software and co-localization between punctae was manually quantified. All images were captured under the same microscope settings and the area of GFP-Ypt6p punctae was measured manually using the Freehand selection tool in ImageJ. 
 
4.2.6 Yeast two hybrid Genes were cloned into the yeast two hybrid vectors, pGADT7 or pGBKT7, and transformed into AH109 and Y187 yeast strains, respectively. Diploids were selected from matings between AH109 and Y187 strains carrying the appropriate genes on minimal medium not supplemented with leucine or tryptophan.  Growth of diploids on medium not supplemented with histidine was used to indicate a positive or negative interaction.  




to generate a pellet (P100) and a supernatant (S100). Pellets were resuspended in sample buffer and equivalent amounts of pellets and supernatants were loaded onto an SDS-PAGE gel and analyzed by Western blot. 
 
4.3 Results 
















Table 4.3 Summary of a subset of TRAPPII interactors by tandem affinity purification 
and mass spectrometry. Selected genes identified by mass spectrometry  are listed in order of greatest # of peptides recovered to smallest and color coded according to their classification in Figure 4.1b (blue = endocytosis; pink =  exocytosis; green = cell wall; olive-gray = GAPs; purple = COPI coat) TRAPP subunits recovered from the mass spectrometry analysis are colored in white.   
4.3.2 YPT6 and its GEF interact genetically with TRAPPII subunits In high throughput screens several genetic interactions have been documented between YPT6 pathway genes and TRAPPII subunits (Tong et al., 2004; Costanzo et al., 2010; Hoppins et al., 2011). To examine how YPT6 pathway genes genetically interact with essential and non-essential TRAPPII subunits, a high copy suppression screen was conducted (Figure 4.2). Included in this study were the RIC1 and RGP1 genes that encode the subunits of the heterodimeric Ypt6p GEF. TRAPPII subunits expressed in high copy plasmids were transformed into ypt6∆, ric1∆ and rgp1∆ mutants that are unable to grow at 37°C. The core TRAPP subunit gene, TRS31, suppressed temperature sensitivity in all three mutants while another core subunit gene, BET5, suppressed the phenotype only in rgp1∆. There was a much stronger phenotypic suppression by TRS31 in ric1∆ and rgp1∆ mutants when compared to ypt6∆, indicating that the requirement for active Ypt6p is being bypassed. Overexpression of YPT1 permits the growth of ypt6∆ at restrictive temperatures and rescues trafficking defects associated with this mutant (Li and Warner, 1998; Ye et al., 2014). The suppression of ric1∆ and rgp1∆ seen with TRS31overexpressionandrgp1∆ withBET5 overexpression may be indirect and mediated  throughYPT1.  Interestingly, overexpression of the TRAPPII specific gene TRS120 made all three strains very sick even at permissive temperature, with the strongest effect seen in ric1∆ and rgp1∆ mutants. Overexpression of TRS33, a gene important for TRAPPII stability, mirrored the effect of 






Figure 4.2 TRAPPII subunits genetically interact with YPT6 pathway genes. TRAPP subunits were overexpressed in ypt6∆, rgp1∆ and ric1∆ strain backgrounds and serial dilutions were plated and grown at permissive (30°C) and restrictive (37°C) temperatures.  
4.3.3 The integrity of TRAPPII is important for interacting with Gyp6 
 In order to continue characterizing the interaction between Gyp6p with TRAPPII, co-immunoprecipitation experiments were conducted in wild type and mutant yeast strains. Of the 10 TRAPPII subunits, Trs33p, Tca17p and Trs65p are non-essential and gel filtration experiments have shown that these subunits are important for complex assembly (Tokarev et al., 2009; Choi et al., 2011). To examine whether the assembly of the TRAPPII complex is important for its interaction with Gyp6p, the endogenous copy of GYP6 was tagged at the carboxy terminus with a triple hemagglutinin (HA) tag and immunoprecipitated from cell lysates. Bet3p, a core TRAPP subunit, was detected by Western analysis to assay for the presence of TRAPPII (Figure 4.3).  In wild type cells, TRAPPII co-precipitates with Gyp6p-HA, confirming Gyp6p as an interacting partner of the TRAPPII complex. This interaction is abrogated in lysates from trs65∆, tca17∆ and 
trs33∆ mutants, indicating that proper assembly of the TRAPPII complex is important for its association with Gyp6p (Figure 4.3a).The deletion of TRS33 and TCA17 have been shown to destabilize the TRAPPII complex, while deletion of TRS65 specifically interferes with TRAPPII dimerization and intact TRAPPII monomers can be purified from trs65∆ cells (Yip 




monomers which contain one copy of Trs130p. It is possible that disrupting TRAPPII dimerization indirectly affects its association with Gyp6p. For example, dimerization may be important for TRAPPII localization to the site of Gyp6p interaction, or be required for upstream events.  Deleting the TRAPPIII-specific subunit TRS85has no effect on the amount of Bet3p co-precipitated with Gyp6p-HA (Figure 4.3A). A small percentage of Bet3p (<0.05%) co-precipitated with Gyp6p-HA despite a very efficient pull-down (not shown), suggesting that the interaction between TRAPPII and Gyp6p is transient, supported by the small number of peptides seen by mass spectrometry (Table 4.3).   Genetic interactions between TRAPPII and YPT6 pathway genes suggest that the interaction between TRAPPII and Gyp6p may be important for regulating Ypt6p pathways. Gyp6p is a GAP for Ypt6p and to determine whether active Ypt6p must be present for TRAPPII to interact with Gyp6p, the same co-immunoprecipitation experiment was conducted in ypt6∆, ric1∆ and rgp1∆ mutant strains.  TRAPPII and Gyp6p interacted to the same degree in these mutants as wild type, indicating that Ypt6p, active or not, is not required for TRAPPII and Gyp6p to interact (Figure 4.3B).  A possible interpretation of this result is that Gyp6p interacts with TRAPPII upstream of its association with Ypt6p.  
 
 






4.3.4 Ypt6p is enriched at the late Golgi in a trs65∆ mutant Recent work showed that Gyp6p is a putative effector of Ypt32p and in a gyp6∆ mutant, Ypt6p remains at the late Golgi for a longer time and has increased co-localization with Ypt32p (Suda et al., 2013). We speculated that TRAPPII is involved in a similar mechanism, and may also recruit Gyp6p to the late Golgi to promote Ypt6p inactivation and dissociation from this organelle. Wild type and mutant strains were transformed with 2 plasmids, one expressing GFP-Ypt6p (Ypt6p) and another expressing Sec7p-mRFP (Sec7p), a marker for the late Golgi. Ypt6p and Sec7p showed a punctate localization pattern, shown in representative fields for each strain (Figure 4.4A).  The percentage of co-localized punctae was quantified and in wild type cells, 29% of Ypt6p co-localized with Sec7p (Figure 4.4B), which is consistent with a previous study (Kawamura et al., 2014).  Co-localization increased almost 3-fold to 79% in a trs65∆ mutant (Figure 4.4B). A less dramatic increase in co-localization was observed in the TRAPPII mutant tca17∆ (49%) and in a gyp6∆ mutant (61%) (Figure 4.4B). The absence of Trs85p, a TRAPPIII-specific subunit, had no effect on co-localization (31%) (Figure 4.4B).   To confirm that the dramatic increase in localization of Ypt6p to the late Golgi observed in trs65∆ is caused by the deletion of TRS65 we attempted to rescue this phenotype. A plasmid expressing the wild type copy of TRS65 was transformed into the 
trs65∆ strain and co-localization between Ypt6p and Sec7p was quantified. When wild type 





Figure 4.4 GFP-Ypt6p  becomes enriched at the late Golgi in a trs65∆ mutant. (A) The localization of GFP-Ypt6p was examined in different strain backgrounds and compared to Sec7-mRFP localization, a late Golgi marker. A representative field of 1-2 cells is shown for each strain background. (B) The percentage of GFP-Ypt6p punctae co-localizing with Sec7-mRFP was quantified in each strain. (C) Co-localization of GFP-Ypt6p and Sec7-RFP was quantified in a trs65∆ strain transformed with either empty vector (empty) or wild type 
TRS65. (For (B) and (C), 56-96 cells, representing 10-15 fields with 3-10 cells each, was counted for each strain. Error bars represent standard error of the mean (SEM)).  Ypt6p localizes to both the early and late Golgi, making it plausible that a portion of the punctae not co-localizing with Sec7p represent early Golgi structures (Suda et al., 2013; Kawamura et al., 2014). To verify this, co-localization between Ypt6p and the early Golgi marker Sed5p was examined (Figure 4.5A). The opposite trend as Sec7p was observed as Ypt6p co-localized with Sed5p more often in wild type (54%) than trs65∆ (32%) and 




compartments, and de-stabilization of TRAPPII oligomers by the deletion of TRS65 causes an enrichment of Ypt6p at the late Golgi.    
 
Figure 4.5 Co-localization of GFP-Ypt6p with the early Golgi is decreased in a trs65∆ 
and gyp6∆ mutant. (A) The localization of GFP-Ypt6p was examined in wild type (WT), 
trs65∆ and gyp6∆ cells and compared to mRuby-Sed5 localization, an early Golgi marker. A representative field of 1-2 cells is shown for each strain. (B) The percentage of GFP-Ypt6p punctae co-localizing with mRuby-Sed5p was quantified in each strain. (31-38 cells representing 5-6 fields of 3-10 cells, were counted for each strain). Error bars represent SEM.  
4.3.5 The localization pattern of GFP-Ypt6p varies between wild type and mutant 
strains In addition to differences in co-localization with Sec7p, Ypt6p punctae in trs65∆ and 
gyp6∆ mutants appear larger and more prominent when compared to wild type. Large variation was seen in the measured area for punctae but interestingly, 21% of punctae in both trs65∆ and gyp6∆ were larger than 0.5 µm2, whereas only 2% of wild type punctae met this criterion (Figure 4.6A). An increased frequency of larger punctae is consistent with an enrichment of Ypt6p to the late Golgi compartment relative to wild type.   Another more striking difference in the distribution of Ypt6p can be observed in 




(Figure 4.4A). The same phenotype was seen in rgp1∆ cells (data no shown). This diffuse localization suggests that Ypt6p is cytosolic but membrane fractionation showed no increase in the ratio of cytosolic to membrane-bound Ypt6p relative to wild type (Figure 4.6B). In the absence of its GEF, Ypt6p does not associate with punctate Golgi structures but does remain associated with membranes. The original study characterizing Ric1p/Rgp1p also observed this localization and hypothesized that inactive Ypt6p localizes to smaller membrane structures such as vesicles (Siniossoglou et al., 2000). 
 
 
Figure 4.6 Higher frequencies of large punctae are seen in trs65∆ and gyp6∆ mutants. (A) The area of GFP-Ypt6p punctae was measured with ImageJ, divided into three categories (<0.2µm2, 0.2-0.5 µm2 or >0.5 µm2) and the frequency of each category was plotted for WT, trs65∆ and gyp6∆ strains. Between 107 and 154 punctae were counted for two experiments. Error bars represent SEM. (B) Subcellular membrane fractionation was performed in WT and mutant strains and GFP-Ypt6p was probed for in each fraction.  












Chapter 5: Discussion 
This thesis provides novel information about the structure of the yeast TRAPP complexes and the contribution of specific subunits, Trs20p and Trs23p in particular, to that structure. This work also provides insight into how a specific mutation in TRAPPC2 leads to the skeletal disorder SEDT through destabilization of the TRAPPIII complex. Finally, the interaction between TRAPPII and a GAP protein was shown to be important for the regulation of its cognate Rab, and may represent a novel mechanism for how TRAPP coordinates membrane trafficking pathways.  
 
5.1 Distinct TRAPP complexes can be resolved biochemically and functionally 
5.1.1 Resolution of the yeast TRAPP complexes is dependent upon lysis conditions 
 At the onset of this thesis work, the TRAPP complex had been extensively characterized in yeast and two complexes were believed to exist, TRAPPI or the core complex, and a larger TRAPPII complex. A third yeast TRAPP complex, TRAPPIII, was discovered through functional studies and employing a different matrix for gel filtration chromatography (Lynch-Day et al., 2010; Choi et al., 2011). Work in Chapter 3 of this thesis showed that under less stringent lysis conditions (150mM NaCl) TRAPPII and TRAPPIII were not resolved by gel filtration chromatography raising the possibility that TRAPPII/III complexes are part of the same complex and dissociate under more stringent (300mM NaCl) lysis conditions. However the TRAPPII subunit Trs130p and TRAPPIII subunit Trs85p failed to co-precipitate under less stringent lysis conditions, even in the presence of a cross linker, supporting the conclusion that TRAPPII and III are indeed separate complexes with distinct roles in membrane trafficking. A similar combination of experiments showed that equivalent TRAPPII and TRAPPIII complexes also exist in mammalian cells and are distinct complexes carrying out independent functions (Bassik et 










Figure 5.1 The SMS domain of Trs23p stabilizes the TRAPP core in yeast. (A) The appearance of a yeast TRAPPI complex when lysates are separated by size exclusion chromatography may be caused by the TRAPP core being released from the two larger complexes. (B) The mammalian homologue of Trs23p, TRAPPC4, lacks the SMS domain. When mammalian cells are lysed the TRAPP core would not dissociate as an intact fragment. 
 
5.1.2 TRAPPIII mediates the tethering of Atg9p vesicles in non-selective and selective 









Figure 5.2 Ypt1p recruits effectors specific to non-selective and selective autophagy 
pathways. TRAPPIII is associated with Atg9p vesicles destined for the PAS. During non-selective autophagy its association with membranes is mediated by Atg9p and is recruited to the PAS by Atg17p. The factors mediating the association of TRAPPIII with membranes and its recruitment to the PAS as part of the selective autophagy pathway have not been identified.  In both pathways, TRAPPIII activates Ypt1p at the PAS leading to the recruitment of Atg1p and Atg11p as Ypt1p effectors, during non-selective and selective autophagy respectively. 
 




completely blocked.  Bet3p palmitoylation can increase the efficiency of TRAPPIII by several possible mechanisms: (i) it could induce structural changes in the TRAPPIII complex; (ii) it could facilitate interactions with other proteins or aid in recruiting the complex to membrane subdomains. Further experiments are needed to distinguish between these possibilities. It would also be interesting to examine whether palmitoylated TrappC3 is also enriched in mammalian TRAPPIII and whether blocking this modification affects autophagy pathways in mammalian cells. The importance of palmitoylation in other trafficking processes regulated by TRAPPIII should also be examined such as endosomal trafficking in yeast and in ER-Golgi transport in mammals. 
 
5.1.4 A mutation that causes SEDT in humans prevents the association of Trs85p 





5.2 TRAPP regulates membrane trafficking pathways by interacting with GTPases 




sequential inactivation and activation of Rabs in membrane trafficking pathways. Additional factors such as MTCs may be necessary to bridge specific RabGAP and RabGEF pairs in these cascades as well as other classes of GTPases, such as Arfs, and their modifying proteins. The requirement for additional factors could provide another layer of regulation to oversee the activation and inactivation of these molecular switches.   
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